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INTRODUCTION 
Infection by specific group A streptococci has been linked to 
the development of autoimmune disease by several investigators 
(Futcher, 1940; Rammelkamp et al. 1952; Stollerman, 1969; McLaren et 
al. 1975; Nissenson, 1975). Models have been proposed to explain 
the role of specific streptococci in autoimmune diseases such as 
post-streptococcal glomerulonephritis and acute rheumatic fever. 
one, the immune complex model (Michael gt al. 1966), proposes that 
the immunopathology observed in post-streptococcal glomer-
ulonephritis is initiated by the deposition of immune complexes con-
taining streptococcal antigen in the glomerular basement membrane. 
This model does not explain the role of specific strains of strep-
tococci in eliciting the autoimmune disease. Moreover, it has been 
difficult to demonstrate streptococcal antigens in such immune com-
plexes. A contrasting model has been proposed which might be called 
the molecular mimicry/autoimmune model. This model proposes that 
antibodies to specific streptococcal antigens are cross-reactive 
with immunologically related glomerular basement membrane antigens 
(Markowitz and Lange, 1964; Lange et al. 1985, 1986; Fitzsimons et 
al. 1987). Experimentally, this model uses monoclonal antibody 
(mAb) raised against streptococcal membrane antigens and cross-
reactive with glomerular basement membrane antigens to. induce tissue 
damage mimicking post-streptococcal glomerular nephritis. Sig-
nificantly, the animal model uses only mAb against streptococcal 
cell membrane to induce glomerular lesions; the animals receive no 
1 
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streptococcal antigen. This mAb shows dose-dependent binding to 
glomerular basement membrane as well as dose-dependent induction of 
disease. Therefore, antigenic similarity between the mammalian 
basement membrane and streptococcal cell membrane must account for 
mAb cross-reactivity. 
This thesis uses a mAb raised against streptococcal cell mem-
brane and cross-reactive with glomerular basement membrane to 
isolate and characterize streptococcal cell membrane antigens. 
These antigens are first isolated by either affinity chromatography 
or by HPLC-gel filtration of digested streptococcal membranes. 
Immunochemical analysis of the antigens is performed using this mAb. 
The immunochemical studies include comparison of reactivities with 
mAb by direct ELISA, competitive inhibition, and affinity chro-
matography, and analysis of antibody binding affinities and valences 
for each antigen by equilibrium dialysis. Structural studies of the 
antigens included amino acid analysis of related antigens as well as 
comparison of reactivities in native and denaturing conditions. 
Analysis of the streptococcal cell membrane antigens using this 
mAb antibody will yield information about the nature of the 
streptococcal membrane epitope. These studies therefore will also 
have implications for the structure of the related glomerular base-
ment membrane antigens. 
LITERATURE REVIEW 
Post-streptococcal Disease 
Incidence and epidemiology 
Acute post-streptococcal glomerulonephritis (APSGN) and acute 
rheumatic fever (ARF) remain common and serious sequelae of strep-
tococcal infection in some parts of the world. Al though the in-
cidence of these post-streptococcal diseases has declined and nearly 
disappeared in Western countries (Gordis, 1985), the incidence of 
these diseases, particularly life-threatening cases of ARF, remains 
high in underdeveloped countries (McLaren et .9.J..., 1975). In South 
Africa and other African countries, ARF is the most common cause of 
acquired heart disease in children; the prevalence among South Afri-
can children can be as high as l, 920 per 100, 000 (McLaren et al. , 
1975). 
The development of APSGN following streptococcal pharyngitis 
occurs after a well-recognized latent period. Following infection 
of the skin, the latent period is 21 to 40 days; after infection of 
the throat, the latent period is only 7 to 15 days (Nissenson et al. 
1979). During this latent period one finds low levels of hematuria 
and albuminuria (Stetson et al. 1955). The clinical disease, re-
ferred to as acute nephritic syndrome, is characterized by edema, 
hematuria, hypertension, and oliguria, but all of these symptoms do 
not necessarily occur in every patient (Rodriguez-Iturbe, 1984). 
Acute nephritic syndrome lasts 4 to 7 days, after which the major 
clinical signs resolve. Although often self-limiting, as many as 25% 
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of these patients develop acute renal failure, as measured by serum 
creatinine of> 2 mg/dl (Rodriguez-Iturbe, 1984). 
Histologic findings include massive mesangioproliferative 
glomerulonephritis. The glomerulus is infiltrated by poly-mor-
phonuclear leukocytes (Sorger et al. 1983), and electron-dense depo-
sits are evident in the subepithelial and subendothelial regions of 
the glomerulus (Lewy et al. 1971; Hinglais et al. 1974; Sorger et 
al. 1983). The subepithelial deposits are considered characteristic 
of this disease, though similar deposits are seen in other diseases 
such as systemic lupus erythematosus and bacterial endocarditis 
(Rodriguez-Iturbe, 1984). Further studies have demonstrated glomeru-
lar deposits of C3, IgG, and IgM in discontinuous, granular patterns 
( Sorger et al. 1983) • Clinical and histologic findings therefore 
point to a role for the immune system in the development of APSGN. 
Etiology of Acute Post-streptococcal Glomerulonephritis 
Post-streptococcal diseases became associated with previous 
infections by group A streptococci, but the incidence of APSGN and 
ARF following group A infection was shown to be markedly different 
(Rammelkamp et al., 1952). Nephritis was associated with group A 
infection of either the skin or throat and the incidence varied 
widely from year to year, while ARF occurred primarily following 
throat infections and the incidence remained fairly constant (Ram-
melkamp et al. 1952). This suggested that only certain strains of 
group A were associated with APSGN. That certain strains of 
streptococci were associated with nephritis was recognized as early 
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as 1917 (Ophuls, 1917), and streptococcal skin infection was first 
associated with acute glomerulonephritis by Futcher (1940), who de-
scribed a previous streptococcal skin infection in up to 28 % of 
acute glomerulonephritis cases. A study of streptococcal infections 
revealed that infection by M-types 1, 2, 4, 12, 18, 25, 49, 55, and 
60 was found to be associated with subsequent acute glomerulon-
ephritis (Stollerman, 1969). Despite many reports that have since 
confirmed these associations, the mechanism by which streptococcal 
infection leads to glomerulonephritis and ARF remains unresolved and 
controversial. 
The etiology of APSGN is especially controversial since many 
mechanisms have been proposed and investigated. Nevertheless, it ap-
pears that the disease is immunologically mediated: a consistent 
latent period exists between the streptococcal infection and the 
onset of nephritis (Michael et al. 1972; Nissenson et al. 1979); a 
regular and transient decrease in serum complement occurs during the 
acute phase of the disease (Gewurz et al. 1968; Kohler and tenBes-
sel, 1969); immunopathological and ultrastructural studies of the 
kidney demonstrate deposits adjacent to GBM, often containing com-
plement and immunoglobulin (Michael et al. 1972; Sorger et al. 
1983) . 
Models for acute post-streptococcal glomerulonephritis 
Serum Sickness and Immune Complex Models for APSGN 
The resemblence of this disease to acute serum sickness did not 
go unrecognized and several serum sickness models for APSGN were 
6 
investigated. In these models (Dixon et al. 1961; Germuth, 1953; 
Wilson and Dixon, 1971) a single and large dose of foreign antigen 
is injected and the disappearance of the antigen from circulation is 
followed. The disappearance is slow until the seventh to fourteenth 
day, when antigen concentration suddenly drops. At this time, immune 
elimination occurs, but the antibody production leads to immune com-
plex formation, drop in serum complement, and finally deposition of 
complement and immune complexes in the glomerular basement membrane 
and mesangium. The role of prolonged exposure to antigen in causing 
serum sickness was investigated (Wilson and Dixon, 1971), and it was 
found that rabbits receiving constant amounts of antigen daily 
varied in their antibody response, but those animals with low to 
intermediate antibody responses did develop nephritis. These 
experiments demonstrate the nephritogenicity of immune complexes, 
but they do not explain the specific role of streptococci in 
nephritis because they did not utilize nephritogenic streptococci or 
streptococcal products. 
Most immune complex models for APSGN do not identify the role 
of streptococcal antigens in immune complex formation and subsequent 
disease. However, the immune complex models do demonstrate the role 
of the antibody response in the pathogenesis of APSGN. Contributing 
to these immune complexes are anti-autologous immunoglobulin. Cir-
culating antiimmunoglobulin titers of 1:32 have been found in up to 
43% of APSGN patients (Rodriguez-Iturbe, 1984) and even higher 
titers early in the disease (Mcintosh et al. 1979). Glomeruli of 
19/22 biopsies from patients had antiimmunoglobulin activity in 
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eluted fractions (Mcintosh et al. 1978) and significant anti-IgG 
activity could be eluted from a kidney in a fatal case. (Rodriguez-
Iturbe et al. 1981). 
How the autologous Ig attains significant immunogenicity has 
been investigated. It was found that autologous IgG could be al-
tered by streptococcal (~. pyogenes) neuraminidase, leading to 
increased immunogenicity of the IgG when injected into animals 
(Mcintosh et al. 1971, 1972). Immunoglobulin alteration by 
streptococcal neuraminidase has been demonstrated for organisms 
isolated from APSGN patients, and it has been shown that the Ig most 
sensitive to streptococcal neuraminidase was IgM (Mosquera et al. 
1985). 
Another mechanism by which anti-Ig could be induced was shown 
to be related to the presence of Fe receptors for IgG in group A 
streptococci (Kronvall, 1973). The high affinity of these receptors 
for light kappa chains and for human serum albumin was shown for 
nephritogenic strains (Vilches and Williams, 1984). These inves-
tigators propose that Ig-coated streptococci could lodge in the kid-
ney and present an altered Ig to the immune system. 
The significance of these observations regarding anti-Ig ac-
tivity in APSGN patients' sera is not clear. Because neuraminidase 
activity is not restricted to streptococci, these observations do 
not explain the specific role of streptococci in eliciting this 
disease. Secondly, Fe receptors also occur on other bacteria and on 
lympho-cytes which, when non-specifically trapped in the glomerulus, 
could present altered Ig to the immune system. The serum anti-Ig 
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activity in APSGN patient's sera could be attributed to each of 
these mechanisms and therefore may not have any significance in the 
initiation of the disease. 
Streptococcal proteins and toxins related to APSGN 
Vilches and Williams (1984) proposed that antibody in the 
glomeruli of APSGN patients could be due to deposition of immune 
complexes containing the antibody bound to circulating streptococcal 
antigens. Alternatively, deposition of streptococcal antigen in the 
kidney could be followed by antibody binding. Another means by 
which antibody could become localized in the glomerulus is by 
specific binding to glomerular antigens cross-reactive with 
streptococcal antigens. Finally, damage to glomeruli due to immune 
complex or streptococcal antigen binding or toxicity could alter 
glomerular antigens and induce auto-reactive antibodies. To address 
these questions, role of specific streptococcal antigens in APSGN 
has been investigated. 
In a model for streptococcal antigen-induced nephritis, M pro-
tein antigens were detected in immune complexes in the kidney (Hum-
air et al. 1969; Kantor, 1965; Kaplan, 1965). When acid-extracted M 
protein type 1 was injected into mice and rats, M protein formed 
complexes with fibrinogen and deposited in the kidney. Repeated 
injections of M protein alone or complexed with fibrinogen also were 
able to induce nephritis in these animals (Humair et al. 1969; 
Kantor, 1965). The presence of M protein in immune complexes in the 
kidneys and the nephritogenicity of M protein when injected does not 
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necessarily implicate M protein in the etiology of APSGN. Second 
attacks of APSGN are extremely rare (Treser et al. 1971), and it is 
believed that immunity to the nephritogenic organism is achieved. 
Since primary exposure to a nephritogenic strain of a particular M 
type tends to protect from second attacks, and several nephritogenic 
M types are known, it is possible that these strains express an 
epitope conserved among their M proteins or express a common non-M 
antigen. Furthermore, circulating antibody from children with APSGN 
was able to bind kidney biopsies independently of the M-type with 
which the children were previously infected (Treser et al. 1971). 
This suggests that antigens are available in the patients' kidneys 
that are recognized by the circulating antibody, and this antibody 
reacts either directly with kidney antigens or with streptococcal 
antigens other than M protein. 
An intracellular streptococcal antigen (Lange et al. 1976) was 
isolated from the supernatant obtained after centrifugation of pres-
sure-disrupted streptococci. This intracellular antigen could ab-
sorb antibodies in convalescing serum, preventing the reactivity of 
the serum antibodies with antigens in the glomeruli. Purification 
by column chromatography and isoelectric focusing revealed a protein 
with molecular weight 43, 000 - 50, 000 and a pI of 4. 7. However, 
detectable titers to this antigen were shown in 10 - 74% of normal 
sera. The role of this antigen in the disease process is therefore 
not clear. 
Vogt et al ( 1983) did chromatofocusing of streptococcal pro-
teins in the supernatant of a defined medium and identified a catio-
10 
nic antigen in the pH range 8-11. This cationic antigen was found 
in 8/18 renal biopsies of patients with APSGN. All 18 sera had 
antibody levels to this cationic antigen. This antigen is thought 
to bind glomerular basement membrane by virtue of its cationic 
nature. 
Villarreal et al. (1979) identified a protein called the neph-
ritis strain-associated protein (NSAP) in the culture supernatant of 
streptococci grown in Todd-Hewitt broth. The molecular weight and 
pI were as described above by Lange ( 1976) • Antibodies to this 
protein were found in serum of 90% of patients with APSGN and in 
serum of 5 - 15% of patients with ARF, but only 13% of normal sera 
had antibody activity. That so many patients had antibody activity 
to this antigen may be because this is a secreted extracellular 
antigen. 
The NSAP from group A streptococci has been identified by 
Johnston and Zabriskie ( 1986). Amino acid analysis and sequencing 
of its 21 amino-terminal amino acids indicate that the secreted ex-
tracellular protein is a streptokinase (MW 46 kd). This strep-
tokinase is related to but antigenically different from that of 
group c streptococci. The streptokinase genes of different strains 
of group A streptococci were analyzed by Huang et al. ( 1989) and 
shown to be extremely heterogenous, although nephritogenic strains 
appeared to be similar in the hypervariable regions of the gene. 
Finally, the nephritis strain-associated protein was shown to 
be a plasminogen activator and was shown to be directly involved in 
the development of nephritis (Holm et al. 1988). In a unique tissue 
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cage model, the investigators were able to demonstrate that 
localized infection of rabbits with NSAP containing strains of group 
A streptococci resulted in binding of this protein to the glomerular 
tissue followed by the development of nephritis in three weeks. 
Animals infected with NSAP-negative strains did not develop nephri-
tis (Holm et al. 1988). The association of this streptococcal 
protein with experimentally-induced APSGN may be related to its 
function as a plasminogen activator. This protein could promote the 
spread of streptococci through conversion of plasminogen to plasmin, 
which could cause subsequent degradation of tissue fibrin. Fibrin 
is often found deposited among the proliferating cells of the 
glomerulus in patients with APSGN (McCluskey et al. 1966; Feldman et 
al. 1966) • However, how this plasminogen activator is involved in 
the immunologically-mediated aspects of APSGN is not clear. 
Autoimmune Model for APSGN 
The immune complex models for the etiology of APSGN do not ade-
quately explain the role of specific streptococci or streptococcal 
products in the pathogenesis of this disease. Other work with anti-
gens isolated from nephritis-associated strains of streptococci has 
been either inconclusive or can not explain the immunologically-
mediated aspects of APSGN. The autoimmune model for the etiology of 
APSGN proposes that the immune response to specific kidney antigens 
results in the immune cascade that leads to the nephritic syndrome 
in APSGN. 
Experimental autoimmune glomerulonephritis has been induced in 
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animals by administering heterologous mammalian antigens or antibody 
to related antigens. Sade et al. (1984) showed development of glom-
erulonephritis in rats that was dose-dependent on the amount of bo-
vine GBM antigen administered. These animals developed lung hemor-
rhages, proteinuria, hypercholesterolemia, hypertriglyceridemia and 
hypoalbuminemia with severity directly related to the amount of he-
terologous antigen injected. However, the linear deposition of IgG 
and lung hemorrhages suggested that this disease resembled Goodpas-
ture' s syndrome or human anti-GBM disease rather than APSGN (Sada et 
al., 1984). 
Another model for autoimmune glomerulonephritis showed that mAb 
prepared against collagenase digested glomeruli caused massive tran-
sient prote·inuria in rats (Orikasa et al., 1988). The mAb localized 
to the slit diaphragms of glomerular foot processes which are 
responsible for the integrity of GBM and its filtration capacity. 
These results suggest a mechanism for inducing the nephritic 
syndrome observed in APSGN and show the autoimmune potential of 
anti-kidney antibody. However, autoimmune models for APSGN must take 
into account the specific role of streptococci. 
The autoimmune model more specifically defined as "molecular 
mimicry" takes into account the streptococcal basis for the disease. 
This model predicts that a specific antigen exists in nephritogenic 
streptococci that is immunologically similar to an antigen in the 
kidney. The molecular mimicry model would explain why specific 
strains of streptococci are associated with the disease. It would 
further explain why certain individuals are susceptible to this dis-
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ease: only those individuals who express the autoantigen would 
suffer the immunopathologic consequences of antibodies to the 
specific streptococcal antigens. 
Early studies suggested that low molecular weight streptococcal 
products were related to APSGN and that antibody to these products 
could cause nephritic syndrome reminiscent of APSGN. Kelly and Winn 
(1958) were able to induce a nephritic syndrome by implanting 
dialysis bags containing live nephritogenic streptococci intraperi-
toneally in rabbits. These observations indicate that a specific 
dialyzable substance from streptococci was responsible for the nep-
hritic syndrome, though the mechanism by which this factor caused 
nephritis remained unclear. In 1959, Matheson and Reed described a 
nephritogenic factor from a group A streptococcus isolated from 
children with APSGN. Rabbit antisera to this factor was able to 
induce nephritic syndrome in rabbits, including hypertension, al-
buminemia, and hematuria (Matheson and Reed, 1959). Antisera to 
other streptococcal fractions could not cause these symptoms. This 
factor was found in cell-free culture filtrates and was found to be 
dialyzable (< 10,000 MW). Further characterization indicated that 
the antigen was neither carbohydrate nor lipid. The < 10, 000 MW 
factor was purified by ammonium sulfate precipitation and the most 
nephritogenic material was found to be precipitated between 65 and 
70% saturation. Thirteen of fifteen ninhydrin spots could be 
identified in paper chromatography as specific amino acids. Further 
characterization of the purified material by paper electrophoresis 
indicated that 6 distinct components could be identified· in this 
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fraction on the basis of their migration properties. Based upon 
these findings, these investigators propose that this factor which 
is able to produce nephritogenic antisera in rabbits is a single 
polypeptide or group of polypeptides of less than 10,000 daltons. A 
factor with similar chemical and physical properties could be 
isolated from non-group A streptococci, but this material did not 
induce nephritogenic antisera in rabbits. The polypeptide antigen 
could not be derived from washed, heat-killed group A cells, but was 
found only in supernatants of growing cells, suggesting that it is a 
secreted intracellular or membrane-associated antigen (Matheson and 
Reed, 1959) . These results support the autoimmune model for APSGN 
because a discrete streptococcal antigen could induce nephritogenic 
antibodies. 
Markowitz ( 1960) proposed an immunologic relationship between 
mammalian glomerular basement membrane (GBM) and group A type 12 
beta-hemolytic streptococci. Markowitz showed that injection of 
this strain of streptococci into the peritoneal cavity of rats 
induced extensive kidney lesions after four weeks. This delayed on-
set of kidney pathology suggested that the immune response to the 
streptococcal infection was responsible for the kidney disease. 
Following these observations, Markowitz and Lange (1964) showed that 
immunization of animals with the streptococcal cytoplasmic membrane 
(SCM) induced the formation of antibodies that reacted directly with 
human glomerular basement membrane antigens. Thus the anti-
streptococcal cell membrane antisera was potentially nephritogenic. 
Anti-SCM serum has also been shown to have an effect· on host 
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tolerance to homografts (Rapaport et al. 1969). Rabbit anti-SCM an-
tisera caused accelerated skin homograft rejection in a high 
percentage of guinea pigs receiving the antisera prior to the graft, 
indicating reactivity of this serum may extend to skin membrane. 
Together, these observations are significant because they point to 
the autoimmune potential of the anti-SCM antisera. 
Other work further supports the role of the streptococcal cell 
membrane ( SCM) in the autoimmune model for APSGN. Treser et al. 
(1970) showed that a component of the plasma membrane derived from 
group A type 12 streptococci could absorb IgG from the sera of APSGN 
patients and thus prevent reactivity with GBM and glomerular mesan-
gium. Only group A abolished reactivity with the kidney sections as 
measured by immunofluorescence. Sucrose density-gradient 
ultracentrifugation of streptococcal fractions localized the 
antigens to the membrane and identified two possible antigens. One 
was soluble in phosphate-buffered saline and the other was 
insoluble. The insoluble fraction was a lipoprotein with MW of 
approximately 120, 000. Significantly, M protein, cell wall, and 
carbohydrate derived from this group A type 12 organsism were unable 
to absorb autoantibody activity (Treser et al. 1970). 
Other work utilizing immunofluorescence has supported these 
findings. Antisera raised against whole basement membrane, or a 
constituent thereof, produce a linear pattern of staining when 
evaluated by indirect fluorescent antibody techniques. In post-
streptococcal glomerulonephritis, however, one sees a granular sub-
epithelial deposition of IgG and complement in the GBM. Using 
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indirect immunofluorescent staining procedures, Blue and Lange 
( 1975) showed that rabbit anti-SCM antibodies bind human GBM in a 
granular pattern. This suggests that the anti-SCM antibodies are 
cross-reactive with distinct spatially defined epitopes in GBM. 
Furthermore, this binding was inhibited if the antisera was pre-
absorbed with either SCM or GBM. 
High levels of anti-SCM antibodies in the sera of APSGN 
patients were reported by Yoshimoto et al. (1987). Only serum from 
APSGN patients could bind Triton-X 100 extracted SCM antigens in 
ELISA and SOS-PAGE isolated antigens in Western blots. At least 
four antigens were detected by Western blotting (though the authors 
do not state the antigen molecular weights they appear to be ap-
proximately 67-70, 40, 25, and 20-22 kd). Four patients reported had 
antibodies only to the largest antigen, while another patient had 
antibodies only to the three smallest antigens, indicating either 
infection by different streptococcal serotypes or genetic 
differences in antibody responses. Unfortunately, the serotype of 
the streptococci with which the patients were infected was not 
known, but the SCM used by these investigators was prepared from 
group A type 12 (Yoshimoto~ al. 1987). 
In summary, evidence from work with different animals and with 
APSGN patients has shown that antibodies to SCM are cross-reactive 
with kidney tissue. Furthermore, antibodies to SCM can cause ac-
celerated graft rejection and APSGN-like disease in animals, in-
dicating that the auto-reactive nature of these antibodies, and not 
SCM antigen itself, is the key to the disease. A critical step in 
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the autoimmune model for APSGN was the development of a simple and 
controlled animal model that demonstrated the autoimmune potential 
of anti-SCM antibodies. 
An animal model for APSGN was developed following the observa-
tions by Lange et al (1985) who showed that rabbit anti-SCM could 
induce glomerulonephritis in mice, and could also induce synthesis 
of murine GBM, a pathology mimicking that seen in the human disease. 
Since this work used heterologous antibody to induce the disease in 
mice, it was possible that the resulting pathology was due to immune 
complexes resulting from species-differences in the immunoglobulin 
administered and not necessarily to the autoreactivity of the anti-
SCM antiserum. Homologous antibody with defined specificity was 
obtained when hybridomas from SCM-immunized mice were produced by 
Lange and Weber ( 1985). Antibodies specific for GBM and SCM were 
detected by ELISA using plates coated with trypsin or collagenase-
digested GBM. Several monoclonal antibodies were produced (Lange 
and Weber, 1986) that were highly cross-reactive with GBM and SCM. 
When these clones were propogated intraperitoneally in mice, the 
animals developed hemorrhagic lungs as well as kidney lesions, 
indicating the ability of these antibodies to react with basement 
membrane other than GBM. The pathology was dose-dependent and 
greater in females than in males. Fitzsimons et al (1986, 1987) 
confirmed reactivity with lung by showing mAb binding to isolated 
soluble lung basement membrane in ELISA. 
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characterization of streptococcal cell membrane 
The pathologic nature of anti-SCM mAb having been established, 
the isolation and characterization of the nephritogenic SCM antigens 
became possible employing these mAbs. Recent work has focused on 
the characterization of SCM antigens rather than the host 
autoantigens for the following reasons: because of the cross-reac-
tivity of these mAbs with GBM and LBM, information regarding the na-
ture of the SCM antigen should have important implications for the 
immunologically related mammalian antigens; SCM is chemically well-
defined, thus analysis of the relatively simple streptococcal cell 
membrane would seem a much easier task than analysis of the complex 
heterogeneous basement membrane; furthermore, SCM is available in 
large amounts and easily isolated in a pure form; finally, SCM from 
a known nephritogenic strain can be employed, whereas basement 
membrane may have individual variations in autoantigen expression or 
uncontrolled and unknown histories. 
Chemical composition of streptococcal cell membrane 
The chemical characterization of streptococcal cell membranes 
has been the subject of a limited number of investigations. SCM has 
been isolated by a variety of methods, including mechanical disrup-
tion of whole cells by glass beads (Markowitz and Lange, 1964) or 
Mickle disintegrator (Freimer, 1963), which result in fragmented 
membrane, and degradation of group A cell wall by streptococcal 
group C phage-associated lysin, which results in wall-free proto-
plasts (Kessler and van de Rijn, 1979; van de Rijn and· Kessler, 
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1979; Freimer, 1963). Whatever the method of SCM isolation, its 
reported chemical composition varies little. 
Freimer (1963) reported that total protein for SCM isolated by 
lysis with the phage-associated lysin was 68% and SCM obtained by 
mechanical disruption in a Mickle disintegrator was 66.9%. In 
another report, SCM obtained by disruption of whole heat-killed 
cells with glass beads was 80% protein (Markowitz and Lange, 1964). 
van de Rijn and Kessler (1979) reported that protein was 70-73% of 
the dry weight of membranes isolated from whole cells by phage-
associated lysin. Though the total protein remained the same 
regardless of the growth phase of the cells, van de Rijn and Kessler 
showed that the level of expression of certain membrane polypeptides 
was altered depending on whether the cells were in exponential or 
stationary phase growth. Several proteins were increased during 
exponential phase, most of which were peripheral membrane proteins, 
though some integral proteins were increased in stationary phase 
(van de Rijn and Kessler, 1979). 
The total lipid composition for membranes ranges from 15-25% 
for SCM from protoplasts and disrupted cells (Freimer, 1963; van de 
Rijn and Kessler, 1979). Total carbohydrate, most of which is gluco-
se, is usually 2% of the membrane weight. Rhamnose is found in 
trace amounts, and less than 0 .1% is characteristic of wall-free 
membrane (Freimer, 1963). Other carbohydrates are all simple sugars 
in trace amounts, including galactose, glucosamine, galactosamine, 
ribose; no sialic acid and only 0.2% hexosamines have been reported 
(Markowitz and Lange, 1964). Phosphorous is 1-3% of the· membrane 
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(Freimer, 1963; Markowitz and Lange, 1964; van de Rijn and Kessler, 
1979) • 
Amino acid analyses by different investigators show consistent 
results. Different investigators have found high concentrations of 
glutamic and aspartic acids (Freimer, 1963; Markowitz and Lange, 
1964; van de Rijn and Kessler, 1979; Agostino and Lange, 1985). 
Immunochemical characteristics of streptococcal cell membrane 
Most work has revealed protein or glycoprotein as the major 
antigenic component of SCM. Using whole rabbit anti-SCM antisera, 
SCM from types 12 and 25 group A streptococci was immunochemically 
characterized (Freimer, 1963). SCM from protoplasts was extracted 
with ethyl ether and ethanol and then digested with either trypsin, 
chymotrypsin, or papain. About 50% of the membrane protein was es-
timated to be solubilized by this treatment. Immunoelectrophoresis 
in agar of the trypsin-soluble SCM ~· rabbit anti-SCM sera showed 2 
overlapping precipitin arcs which migrated toward the cathode 
(Freimer, 1963). Capillary precipitin assays also showed antigens 
in SCM boiled 10 m at pH 2.0. How this material was related to the 
enzyme-digested antigens was not clear. 
SCM obtained by disruption of type 12 whole cells was extracted 
with the fluorocarbon trifluorotrichloroethane and the soluble 
fraction from the aqueous phase was digested with trypsin (Markowitz 
and Lange, 1964). This material was immunochemically characterized 
by immunodiffusion, passive cutaneous anaphylaxis, and passive 
hemagglutination. Rabbit antisera against this SCM fraction was 
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found to be cross-reactive with human glomerular basement membrane 
by each of these methods. The soluble SCM fraction was determined to 
be 8.5 kd by ultracentrifugation, amino acid analysis, and chroma-
tography with Sephadex (Markowitz and Lange, 1964). Electrophoretic 
analysis showed that the SCM antigen contained one component which 
migrated toward the anode, and possibly two toward the cathode. 
This SCM fraction which showed immunologic similarity with GBM was 
further chemically characterized by Lange and Markowitz (1969). 
Digestion of this fraction with papain and peptide mapping with high 
voltage electrophoresis yielded a peptide fingerprint very similar 
to that obtained for GBM. This cross-reactive material was found in 
SCM extracted with SOS, CNBr, or deoxycholate, but not with TCA, 
pancreatic lipase, Triton X-100, 2-chloroethanol, pepsin, or 
collagenase (Lange, 1969). DEAE cellulose chromatography of each 
soluble preparation yielded one fraction eluted with 0.01 M 
phosphate, pH 7. 75, which was cross-reactive in agar gel analysis 
with GBM (Lange, 1969). These results gave the first immunochemical 
data for SCM antigens which are immunologically related to GBM. 
The role of glycoprotein carbohydrate in the reactivity of SCM 
and GBM antigens with anti-SCM antisera has been examined (Blue and 
Lange, 1975, 1976a, 1976b; Blue et al. 1980). Indirect im-
munofluorescence demonstrated that anti-SCM antisera binding to GBM 
increased when the GBM was pretreated with carbohydrase (Blue and 
Lange, 1975), indicating reactivity of the antisera with a protein 
epitope. Thus, the carbohydrates removed by treatment with car-
bohydrase were thought to "mask" the dominant protein epitopes in 
22 
GBM. When antisera ;.ras prepared to "carbohydrate-rich" SCM, this 
antisera showed no cross-reactivity with GBM (Blue gs. 5l· 1980). It 
was concluded that the '3pitope in SCM and GBM responsible for the 
antisera cross-reactivity was protein. 
Specific aims of ~resent work 
Guiding this investigation is the hypothesis that the observed 
cross-reactivity of anti-SCM antisera and mAb with GBM is due to 
molecular similarities between these antigens. Therefore immuno-
chemical characterization of SCM antigens using an anti-SCM mAb 
cross-reactive with GBM should have implications for the GBM 
antigen. 
The aims of this work are to isolate streptococcal cell mem-
brane protein antigens immunologically related to glomerular base-
ment membrane, to characterize the interaction of the antigens with 
the mAb and to identify minimal structural requirements for 
reactivity of the SCM antigens ;.rith the mAb. Isolation of SCM anti-
gens is accomplished with anti-SCM mAb affinity columns and by HPLC 
gel filtration. The reactivities of the antigens recovered are then 
analyzed and compared by ELISA, competitive inhibition, and affinity 
chromatography. :nteraction of ~he recovered antigens with mAb is 
further characterized by equilibri:.un dialysis. Analysis of the 
minimal structural requirements for antigenicity is attempted by 
amino acid analysis and 3equencing of ~urif ied antigens and a study 
of their reactivity with :nAb in ~ative and denaturi~g conditions. 
MATERIALS AND METHODS 
Monoclonal antibody 
Spleen cells from mice (6 wk old Balb/c) immunized with par-
ticulate SCM in complete Freund's adjuvant were fused with P3-X63-
Ag8 nonsecretor plasmacytoma cells as described by Fitzsimons et al. 
(1987) using the procedure of Goding (1980). Clones showing reac-
tivity to both SCM and GBM by ELISA were selected by limiting dilu-
tion three times to insure monoclonality. Ascites was prepared from 
the reactive clones as descibed by Fitzsimons et al. (1987) and the 
ascites and serum were employed as the source of mAb. Ascites from 
non-immune animals or animals carrying the fusion partner alone did 
not exhibit anti-SCM activity (Fitzsimons et al. 1987). 
Determination of monoclonal antibody isotypes 
Isotyping was performed with monoclonal anti-mouse isotype 
antisera (Hyclone, Logan, UT.) according to the manufacturer's 
directions. Briefly, goat anti-mouse isotype specific (T1, T2a• T2b• 
T3, a1, a2, µ) antibodies were coated (100 ul/well) on ELISA plates 
(Falcon) for 1 h at 22°c. The plates were washed and 100 ul ascites 
was added to each well. After 1 h at 22°c, the wells were washed 
and alkaline phosphatase-conjugated goat anti-mouse immunoglobulin 
was added to each well to detect the captured ascites 
immunoglobulin. After incubation for 1 h the plates were washed and 
150 ul p-nitrophenol phosphate (20 ug/ml) was added to each well and 
the amber color allowed to develop. The reaction was stopped by 
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addition of 50 ul O.lN HCl to each well. 
Affinity purification of mAb from ascites 
SCM tryptic digests were coupled to two different gel media to 
affinity purify mAb from ascites. The first column was made using 
cyanogen bromide-activated Sepharose. Sepharose gel was first 
swelled in 0.001 M HCl on a glass filter and then washed with dis-
tilled water. The slurry was added to 100 ml 2 M sodium carbonate 
and mixed thoroughly. To 50 ml packed volume gel was added 5 ml 
cyanogen bromide solution (cyanogen bromide 2 gm/ml in 100% acetoni-
trile) with vigorous stirring for 2 m. The gel was poured into a 
coarse sintered-glass funnel under vacuum and washed with 300 ml 0.1 
M sodium bicarbonate, pH 9.5, 300 ml deionized water, followed by 
300 ml 0.2 M sodium bicarbonate, pH 9.5. The gel then was suctioned 
until it was a firm moist cake and then transferred to a bottle with 
50 ml 0.2 M sodium bicarbonate, pH 9.5. The antigen was added with 
constant gentle stirring at 4°c for 20 h. After coupling, 5 ml 1 M 
glycine was added to block reactive sites and mixed for 4 h at 4°c. 
The gel then was transferred to a sintered-glass funnel and washed 
with 20 volumes (1 l) 0.1 M sodium acetate, pH 4.0, 1 liter 2 M 
urea, 1 l 0.1 M sodium bicarbonate, pH 10. The gel was reconsti-
tuted in 50 ml PBS, degassed, and used immediately. The second 
column was a carbonyldiimidazole-activated support (Reactigel, 
Pierce Chemical Company, Rockford, IL). The pre-activated gel (15 
ml final volume) was coupled with the antigen in PBS, pH 8.5, for 30 
h at 4°c. The gel required no blocking and was used after washing 
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in a sintered-glass funnel with PBS. 
The efficiency of antigen coupling to the gels was monitored by 
taking samples of the supernatants at 4 h and at the end of the 
coupling time period. The supernatants were assayed for protein 
content using the BCA method (see "Protein determinations") which 
showed that 4.7 mg SCM was bound per ml of the Reactigel media and 
3.0 mg SCM was bound per ml of the CNBr-activated Sepharose. HPLC 
analysis of the supernatants indicated that the gels bound most of 
each peptide in the SCM digest (11.6, 9.2, 7.0, 4.7, 2.3 kd), but 
the Reactigel did not efficiently bind the 4. 7 kd and the CNBr-
Sepharose did not bind the 9.2 kd. 
To each 1 x 10 cm column were added samples of ascites ( 200, 
100, 50 ul) in PBS. The columns were washed with PBS 1 drop/15 s. 
The effluents were collected and the columns were washed with 0.1 M 
glycine-HCL, pH 2.0, at a flow rate of 1 drop/6 s. The eluent was 
collected in PBS, pH 8.0, and then neutralized with 0.1 N NaOH. 
The presence of mAb activity in these effluents and eluates was 
evaluated by ELISA using SCM-coated plates. 
Euglobulin precipitation of IgM mAb 
IgM mAb was purified by euglobulin precipitation (Garcia-Gon-
zalez et al. 1988) from ascites fluid and pooled serum of mice 
carrying one particular clone. Following dialysis against two 
changes distilled water for 20 h at 4°c, the recovered IgM-rich 
precipitate was solubilized in borate buffered saline, pH 8.4. 
IgM content was determined by serial dilutions employing ELISA 
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plates coated with goat anti-mouse IgM (Hyclone, Logan, UT). ELISA 
plates were coated with goat anti-mouse IgM 6.0 ug/ml in PBS, pH 
7.4, for l h at 22°c. The plates were washed 15 times with PBS con-
taining 0.03 % Tween-20 (PBS-Tween). The IgM-rich preparation, the 
starting ascites, and the supernatants of the precipitations were 
added to the wells (100 ul/well) at various dilutions (1:100 to 1:-
106 ). TEPC, a BALC/C myeloma IgM, was added to separate wells at 
various dilutions for direct comparison and determination of IgM 
content in the various preparations. After incubation for l h at 
22°c, the wells were washed 15 times with PBS-Tween and to each well 
was added 100 ul horseradish peroxidase-conjugated goat anti-mouse 
immunoglobulin, 0.2 ug/ml in PBS. The plates were incubated for l h 
at 22°c and washed 15 times. The substrate was added as described 
in "Enzyme-linked immunosorbant assays" and the color development 
measured at 405 nm as described. The absorbance was plotted ~· the 
inverse dilution of mAb. The concentration of IgM mAb was calculated 
from three points in the linear portion of the curve and by 
multiplying the mAb dilution factor by the known TEPC concentration 
at each absorbance. The average value was 2.21 mg/ml; protein 
determination using the bicinconinic acid protein assay gave a value 
of 2 .10 mg/ml. 
Purity of the precipitated mAb was assessed by cellulose ace-
tate electrophoresis and sodium dodecyl sulfate polyacrylamide elec-
trophoresis (SDS-PAGE). The recovery of IgM mAb activity was tested 
in ELISA using trypsin-digested SCM as the solid phase antigen. 
27 
Isolation of basement membrane antigens 
Human renal cortex and lung were obtained from the National 
Disease Research Interchange (NORI, Philadelphia, PA). Mice were 
Balb/c 1-6 months old, and were housed in the Animal Research Faci-
lity of Loyola University Stritch School of Medicine. 
Purified BM was prepared by the procedure of Carlson et al. 
(1978) and as described by Lange (1980a). All solutions were kept 
cold and work was done on ice. Murine kidney was pressed gently 
through a 200 mesh screen; human kidney or lung was similarly pro-
cessed using 100 mesh screen. The screen was washed with phosphate-
buffered saline (PBS), pH 7.4, and the remaining tissue was pushed 
through. Processed tissue was collected in a watch glass and placed 
in a 50 ml conical centrifuge tube filled with PBS containing tannic 
acid (tPBS, 50 mg tannic acid/l PBS). The tubes were shaken well 
and the contents allowed to settle for 30 m. After 30 m, 2/3 of 
each tube was aspirated. The tubes were refilled with tPBS and the 
contents allowed to settle for 30 m. This settling was repeated 3 
times. The tubes then were centrifuged 10 m at 700xg. The PBS 
supernatants were aspirated and replaced with 8 ml H2o (0.05% sodium 
azide). The contents were allowed to settle for 2 h at 22°c. The 
tubes then were centrifuged 10 m at 700xg. The supernatants were 
aspirated and the sediments resuspended in 3% Triton X-100. The 
contents were allowed to settle at 22°c for 2-4 h. Following 
centrifugation and aspiration of the supernatant, deoxyribonuclease 
(0.001 % in 1.0 M NaCl, Sigma, St. Louis, MO) was added and the 
sediment was resuspended and incubated for 1-2 h at 37°c. ~he tubes 
28 
then were centrifuged and the supernatants aspirated. To each tube 
was added 4% sodium deoxycholate in 0.05% sodium azide. After 20 m 
at 22°c the tubes were centrifuged and the supernatants removed. 
The sediment were washed with 0.05% sodium azide 5 times. The clear 
supernatant was aspirated, and the sediment was frozen at -4°c. 
Microscopic examination of this sediment confirmed the presence of 
glomeruli free from cellular debris. This observation is consistent 
with the results obtained by Carlson et al. (1978) and Lange 
( 1980a). 
Purified BM was digested with trypsin (Sigma, St. Louis, MO). 
A 1 mg/ml trypsin solution (0.1 M NH4HC03 0.1 mM CaCl2, pH 8.0) was 
added to BM (1 mg trypsin/100 mg BM) and tubes were rotated for 20 h 
at 37oC. The undigested material was removed by centrifugation. The 
supernatants of these enzyme digestions were dialyzed against 
several changes of distilled H2o at 4°c and then concentrated by 
vacuum centrifugation. The soluble protein content was determined 
by the BCA method (see section titled "Protein determinations"). 
Isolation of streptococcal membrane antigens 
The strain employed exclusively was group A M-type 12 
~.pyogenes Hektoen strain (Markowitz and Lange, 1964). Whole cells 
of heat killed Type 12 streptococci were washed in saline repeatedly 
at 13,000xg until the supernatants measured < 0.2 absorbance units 
at 278 nm. The cells were disrupted with the Bead Beater cell dis-
rupter (Biospec Products) using 0.1 mm diameter glass beads 
previously washed with 50% sulfuric acid followed by several washes 
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with distilled water. The chamber was half filled with beads and 
then approximately 100 gm wet weight whole cells were added. The 
chamber was filled to the mouth with water to exclude air and then 
surrounded with ice. The cells were disrupted by five cycles of 5 m 
of disruption followed by 5 m of rest. 
Differential centrifugation with a continuous flow head in a 
Sorvall refrigerated centrifuge separated whole cells and wall 
material from membrane (see Results). 
was dialyzed and frozen or lyophilized. 
Pelleted wall and membrane 
Rhamnose determination of 
the membrane confirmed its purity (described in detail below). Con-
tamination with wall-derived M protein was assessed by inhibition 
ELISA: SCM was added to anti-M 12 antisera which was then assayed 
for reactivity on M 12-coated ELISA plates. 
Rhamnose content of streptococcal cell membrane 
The procedure of Dische and Shettles (1948) was used to deter-
mine the rhamnose (methyl pentose) level in the membrane prepara-
tion. A level of < 0.1% is acceptable for wall-free streptococcal 
cell membrane (Freimer, 1963). To ice cold standard solutions of 
methyl pentose (2.75, 5.50, 8.25, 10.0 ug/ml in 1 ml distilled 
water) were added 4.5 ml chilled sulfuric acid (6 parts concentrated 
sulfuric acid:l part deionized water) slowly, with constant shaking 
in an ice bath. After standing for 10 m at 22°c, the tubes were 
placed in a boiling water bath for 3 m. The tubes were allowed to 
stand several m at 22°c. To each tube was added 0.1 ml 3% cysteine 
hydrochloride. The contents were mixed, and after 2 h the ab-
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sorption at 396 run and 430 run was measured. Subtraction of the 
absorbance at 430 from the absorbance at 396 corrects for all absor-
bance except that due to methyl pentose. The SCM samples were first 
digested in concentrated sulfuric acid and boiled for 3 m. They 
then were used in the assay. The % rhamnose was determined by ex-
amining the standard curve and assigning a concentration to the 
unknown. 
Preparation of soluble SCM antigens 
SCM was solubilized with trypsin or with sos. Trypsin diges-
tion was as described for BM antigens. SCM was solubilized with SOS 
by mixing 20 mg SCM with 1% sos in PBS for 1 h at 22°c. The sos-ex-
tracted SCM was centrifuged 14, OOOxg 10 min to remove particulate 
material. The supernatant was dialyzed at 4°c for 48 h against 
several changes 0.1 M KCl, 0.05% NaN3. The supernatant was collected 
and dialyzed against distilled H2o 4 h at 4°c. The supernatant was 
collected and concentrated. The concentrated extract was passed 
over a 10 cm column of Biobeads SM2 adsorbant (Biorad) equilibrated 
in 10 mM KP04, pH 7.2. One ml extract was layered on the column and 
the column was washed with 10 ml 10 mM KP04 . Fractions were 
collected and assayed for protein by BCA as described in "Protein 
determinations". The column was regenerated by washing with 4 bed 
volumes distilled H20 followed by 4 bed volumes methanol, finishing 
with 4 bed volumes of distilled H2o. 
Both SOS-extracted and trypsin-digested SCM were screened for 
soluble antigens as described in "Immunoblot of SCM antigens". 
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Type-specific M-12 proteins 
Type-specific M-12 protein was obtained by hot-HCl extraction 
and purified as described by Lange et al. ( 1969). Cell walls were 
stirred with hot concentrated HCl. Insoluble material was removed 
by centrifugation. The supernatant was neutralized with 6 N NaOH and 
the crude M protein extract was fractionated by ammonium sulfate 
precipitation between 30 and 60 % saturation. After dialysis and 
lyophilization, samples were dissolved in phosphate buffer 0.005 M, 
pH 7.75, and chromatographed on diethylaminoethyl cellulose columns. 
Elution was stepwise with buffers of increasing ionic strength and 
decreasing pH. Individual peaks were collected and 
rechromatographed on carboxymethyl cellulose equilibrated with 0.01 
M, pH 2.5 glycine buffer. 
Clg purification 
Clq was purified from human serum by three cycles of precipi-
tation at low ionic strength as described by Yonemasu and Stroud 
(1971). Fresh serum (240 ml) was dialyzed with stirring for 18 hat 
4°c against 4 l of the following solution: 0.01 M EDTA, 0.005 M 
NaN3, 0.0005 M phenylmethylsulfonylfluoride, pH 6.0. The serum was 
centrifuged to remove residual red cells and clots. The serum was 
then dialyzed with stirring against 4 l 0.026 M EGTA, 0.03 M NaCl, 
pH 7.5 for 4 h at 4°c. The dialysate was changed and dialysis con-
tinued in the same buffer for 15 h at 4°c. The precipitate was 
collected by centrifugation and washed in the dialysis buffer. The 
precipitate was redissolved in 25 ml of 0.75 M NaCl, 0.01 M EDTA, 
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0.02 M acetate, pH 5.0. Aggregated material was removed by 
centrifugation. The redissolved precipitate was then dialyzed with 
stirring against 4 l of 0.06 M EDTA 0.065 M NaCl, pH 5.0 for 4 h at 
4°c. The precipitate was recovered by centrifugation and washed in 
the same fresh dialysis buffer. The precipitate was redissolved in 
25 ml 0.75 M NaCl 0.01 M EDTA 0.005 M NaH3HP04, pH 7.5. Aggregates 
were removed by centrifugation. The redissolved precipitate was 
then dialyzed with stirring against 4 l of 0.0035 M EDTA 0.069 M 
NaCl, pH 7.5 for 4 h at 4°c. The precipitate was collected by 
centrifugation and washed by resuspension and centrifugation in the 
same fresh dialysis buffer. The precipitate was redissolved in 1.0 
ml 0.75 M NaCl O.Ol M EDTA 0.02 M acetate, pH 7.5. The protein 
content was determined by BCA as described in "Protein deter-
minations". The purity was confirmed by cellulose acetate electro-
phoresis (see "Cellulose Acetate Electrophoresis") of the starting 
serum, the supernatants of the first, second, and third precipita-
tions, and the material obtained in the third precipitation. 
Clq was diluted in high-salt PBS-EDTA (0.64 M NaCl 0.01 M EDTA, 
pH 7.8) to a concentration of 25 ug/ml and coated 100 ul/well on 96-
well ELISA plates for 1 h at 22°c. The wells were emptied and the 
supernatants saved. Uncoated sites in the wells were blocked by the 
addition of 1 % BSA in PBS (0.01 M EDTA) 100 ul/well at 22°c for 2 
h. 
Protein determination 
Protein concentrations were determined by the bicinchoninic 
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acid assay as described by Smith et al. {1985) {Pierce Chemical Com-
pany, Rockford, IL). To each well of an ELISA plate {Falcon) was 
added 10 ul of each sample with 200 ul BCA working reagent. 
standard concentrations of bovine serum albumin {Pierce) were added 
to separate wells of the same plate. A blank consisting of 10 ul 
solvent and 200 ul BCA working reagent was prepared. The plate was 
covered and incubated 30 min at 37°c. The blue-green color was read 
at 570 nm in a Dynatech {Alexandria, VA) model 500 ELISA reader. 
Comparison of unknowns to the standard curve permitted determination 
of protein concentrations. This assay is sensitive to protein 
concentrations in the range of 10 to 1200 ug/ml {Smith et al. 1985). 
High pressure liquid chromatography 
The HPLC system includes the Waters M-45 solvent delivery 
system and model 440 absorbance detector (Millipore, Bedford, 
Mass.). The columns used were the Waters I-125 and the DuPont GF-
250 {DuPont, Wilmington, Delaware), both gel filtration columns. 
The I-125 (7.8 mm x 30 cm) is composed of a bonded silica support 
and is able to separate proteins of 2-80 kd. The silica based 
packing is compatible with aqueous solutions and separates by size 
proteins with acidic, neutral, and mildly basic pis. The GF-250 (9.4 
mm x 25 cm) is a zirconia-stabilized silica support capable of 
separating proteins of 2-250 kd. 
All solvents used in HPLC were filtered before use with a 0.45 
um pore size 44 mm filter {American Scientific Product!?, McGraw 
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Park, Il.). All samples were centrifuged to remove particulates and 
then filtered before injection. The I-125 was run in 0.05 M NaH2P04 
pH 7.8 at 2 ml/min and the GF-250 was run in 0.1 M Na2HP04 pH 6.0 at 
l ml/min. 
A standard curve was prepared using the HPLC Molecular Weight 
Marker Kit (United States Biochemical Corp., Cleveland, OH.), which 
contains glutamate dehydrogenase (290 kd), lactate dehydrogenase 
(140 kd), enolase (67 kd), adenylate kinase (32 kd), and cytochrome 
c (12.4 kd). The molecular weight markers from Sigma were also used. 
These were bovine serum albumin (66 kd), carbonic anhydrase (29 kd), 
cytochrome c (12.4 kd), and aprotinin (6.5 kd). The column was run 
with 0.1 M Na2HP04 pH 7.2-7.4. The average retention time of seve-
ral runs was used to make a standard curve by plotting log molecular 
weight ~· the retention time of the protein in m. Molecular 
weights of unknown samples were determined from the standard curve. 
Reverse-phase HPLC was accomplished using the Varian HPLC 
system. Gradients of 0.1% TFA to 60% acetonitrile in 0.1% TFA were 
employed with Cl8, ca, and C4 reverse-phase columns. 
HPLC-affinity chromatography 
Coupling of IgM mAb to tresyl-activated columns 
IgM mAb purified by euglobulin precipitation from ascites and 
serum was passed over the tresyl-activated silica-based columns (5 
cm x 1 cm, Pierce Chemical Company, Rockford, IL). Three individual 
affinity columns, one for each membrane digest, were activated by 
pumping through 7 ml mAb (at 5 mg/ml in 0.2 M phosphate buffer, 0.5 
35 
M NaCl, pH 7.4) at 1 ml/m. The amount of mAb loaded was determined 
as described in "Monoclonal antibody"; the amount of mAb in the ef-
fluents was determined from the absorption at 278 run of the effluent 
and the absorbance coefficient for IgM ( 1. 3 for a 0 .1% solution). 
From these were calculated the amount of IgM bound to the column. 
The column effluents were recycled and the effluents monitored until 
it was determined that the columns were not binding additional mAb. 
Affinity isolation of membrane antigens 
Membrane preparations were loaded onto their respective mAb 
affinity columns in running buffer (O.l M Na2HP04, pH 7.8). The 
columns were washed with three volumes of running buffer, the ef-
fluents collected, and the specifically bound antigens were eluted 
with 5 ml 1 M acetic acid, pH 2.0. The specifically eluted antigen 
was collected and neutralized with 0.1 N NaOH. Each eluate was ana-
lyzed by HPLC gel filtration. Eluted material was concentrated to 
the volume in which the sample was loaded and the protein concentra-
tion was determined by BCA. The concentration of eluted antigen 
was also determined by comparing the areas of the elution curves to 
the eluent curves by planimetry. Antigen:antibody runole ratios were 
determined from the amount of antigen eluted and the runoles of mAb 
(calculated based ug amount bound and molecular size of 800 kd) 
bound to the matrix. 
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Specificity of the mAb affinity column 
The specificity of the mAb column was assessed by loading 
related and unrelated proteins on the column. Bovine serum albumin 
(BSA), M-types 12 and 48 streptococcal M protein and mouse serum al-
bumin each were loaded on the column and the effluents and eluates 
collected. The amount of protein loaded, in the effluent, and in 
the eluate was measured by BCA and by monitoring the absorption of 
each at 278 nm. Amino acid analysis was performed on the M48 eluate 
to assess whether low amounts of protein were binding to the 
affinity column. The M48 eluate amino acid composition was compared 
to that of various buffer and background controls and acid washes. 
Finally, M12 protein was loaded on the column and the effluent and 
eluate collected, concentrated, and resuspended in the same volume 
in which M12 was loaded. These were coated on ELISA plates and 
assayed for the presence of Ml2 with rabbit anti-M12 antibody. 
Electrophoresis 
Cellulose acetate electrophoresis 
Separaphore cellulose acetate membranes ( 5 x 15 cm, Gelman 
Sciences) were wetted in running buffer (0.075 M barbital buffer, pH 
8.6) and samples applied with the Beckman sample applicator. Mem-
branes were loaded into the Beckman Model R-101 microelectrophoresis 
chamber. Electrophoresis was run 20 or 30 m at 60 v. Membranes were 
stained with 0.2% Ponceau S (in 3.0% trichloroacetic acid) 10 m and 
destained in 5.0 % acetic acid. 
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sodium dodecylsulfate polyacrylamide electrophoresis 
SOS-PAGE analysis was accomplished essentially by the procedure 
of Laemmli (1970). The running gel contained 10% w/v acrylamide and 
0.1% w/v SOS in 0.375 M Tris-HCl buffer, pH a.a. The stacking gel 
contained 3.0% w/v acrylamide and 0.1% SOS in 0.125 Tris-HCl buffer, 
pH 6.8. Samples were boiled 1.5 m in sample buffer which consisted 
of 2.0% w/v SOS, 10% v/v glycerol, 5% v/v 2-mercaptoethanol 
(Eastman), and 0.001% w/v bromophenol blue in 0.0625 M Tris-HCl buf-
fer, pH 6.a. To initiate polymerization, 0.025 % tetramethylethyl-
enediamine (Eastman) and ammonium persulfate (Fisher) were added to 
the gels. Slab gels (1 mm thick) were poured between glass plates 
15.9 x 14 cm and allowed to polymerize. The upper tank buffer con-
tained 0.1% sos in Tris-glycine buffer, (0.025 M Tris, 0.192 M 
glycine), pH a.7. The lower tank buffer contained 0.5 M Tris-HCl, 
pH a.1. Electrophoresis was carried out at 30 mA/gel for 2 hs. 
Molecular weight standards (Sigma) were included with each gel. 
These contained bovine serum albumin, carbonic anhydrase, 
phosphorylase b, lysozyme, soybean trypsin inhibitor. 
Gels were fixed and stained with Coomassie brilliant blue 
(BioRad). Coomassie staining was accomplished with 0.1% Coomassie 
in 7.0% trichloroacetic acid. Oestaining was done with 25% 
methanol, 10% acetic acid in water. 
Immunoblot and Western blot of soluble SCM antigens 
Following electrophoresis, SOS-PAGE gels were equilibrated in 
electrotransfer buffer (0.1 M 3-(cyclohexylamino]-l-propanesulfonic 
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acid, pH 11.0, Sigma) for 10 m. PVDF membrane (Millipore) was cut 
to the size of the gel (approximately 9 x 12 cm) and wetted 5 s in 
100% methanol. The membrane and two sheets Whatman filter paper cut 
to the size of the gel were soaked in electrotransfer buffer. The 
membrane was positioned over the gel with care to avoid air bubbles 
between the gel and membrane. Bubbles were removed by rolling a 
clean pasteur pipette over the membrane. The membrane and gel were 
placed between pieces of filter paper and oriented with the gel 
toward the anode and the membrane toward the cathode in the Trans-
blot Apparatus ( Biorad) • The transfer was run at 30 v, 0.10 amps 
for 18 h. Tap water was run via coiled tubing through the transfer 
chamber to maintain cool transfer temperature. After 18 h, the 
potential was raised to 45 v for 2-3 h. 
The staining procedure described below applies to both electro-
transferred protein and to blotted proteins ( immunoblotting). The 
nitrocellulose or PVDF membranes bearing the antigens were rinsed 
briefly in PBS and were blocked for 30 m with 10 mM Tris-HCl, pH 
7.4, containing 3 % BSA and 0.9% NaCl. 
membranes were washed with 3 changes of PBS. 
After blocking, the 
To the membranes was 
added mAb diluted 1:1000 (if ascites, diluted 1:100). The membrane 
was rocked for l h at 22°c and washed 5 times with PBS, 5 m per 
wash. Horseradish peroxidase-conjugated goat anti-mouse im-
munoglobulin (Hyclone) was added 1:3000 and the membranes rocked for 
1 h at 22°c. The membranes were washed 4 times in PBS and sub-
strate, 1,4-chloronapthol and H202 , was added and the color allowed 
to develop. Substrate was made by combining immediately before use a 
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solution of 15 mg 1,4-chloro-napthol in 15 ml methanol with a solu-
tion of 70 ul 0.3% H202 in 25 ml PBS. 
Enzyme-linked immunosorbant assay 
Antigens were coated on polystyrene 96-well plates (Falcon) at 
a concentration of 2.5-10 ug/ml in 0.1 M sodium carbonate buffer, pH 
9.6, and incubated 18 h at 22°c. The uncoated sites were blocked by 
incubating the wells with 1% human serum albumin (HSA) in phosphate 
buffered saline (PBS), pH 7.4 for 3 h at 22°c. Plates were washed 
15 times with PBS containing 0.01% Tween 20. Ascites or mAb was 
serially diluted in PBS and incubated 100 ul/well for 1 h. After 
washing, horseradish peroxidase-conjugated goat anti-mouse immuno-
globulins (Hyclone, Logan, UT) 1:10,000 (0.2 ug/ml) in PBS con-
taining 0.5% HSA were added and incubated for 1 h. The plates were 
washed and the substrate containing 2,2 azinodi-(ethyl benzthio-
zoline sulfonic acid) (EBS) and H202 was added. The substrate was 
made fresh by combining 1:1 a solution of 2 ug/ml EBS in citrate 
buffer, pH 4.1 with a 0.3% H202 solution in water. After 10, 20, 
30, and 60 m the plates were read at 405 nm in a Dynatech 
(Alexandria, VA) model 600 ELISA reader. 
Competitive inhibition of ELISA 
Competitive inhibition was performed by two different methods. 
In the first, 50 ul mAb in PBS was incubated (l h at 37°c, sometimes 
followed by 18 h at 4°C) with 50 ul antigen in PBS resulting in 
final mAb concentration at 0.25 pmoles and final ant~gen con-
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centration ranging from 0.005 to 2000 pmoles. The mAb was also in-
cubated without inhibitor added to determine the effect of incuba-
tion on mAb activity. The second method was designed to enhance the 
inhibition of the mAb by low molecular weight antigens. In this 
case inhibition (using same concentrations and volumes as above) was 
performed in Clq-coated ELISA plates in order to selectively remove 
antigen-bound mAb. Clq-coated ELISA plates were prepared as 
described in "Clq purification". Antigens (SCM polypeptides puri-
fied by HPLC and streptococcal M 12 protein) were incubated with the 
mAb in Clq-coated wells for l h at 37°c. The individual well super-
natants were transferred to SCM-coated plates to assay mAb activity 
in ELISA. The effect of Clq on unabsorbed mAb was measured by 
incubating the various dilutions of mAb in Clq-coated wells and tr-
ansferring the supernatants to SCM-coated plates to measure mAb ac-
tivity. Inhibition was also run under identical conditions in ELISA 
plates coated with BSA instead of Clq. 
Comparison of native and denatured polypeptide antigens 
The reactivity of native and denatured SCM peptides with mAb 
was compared by ELISA. ELISA plates were sensitized with fractions 
boiled for 30 m or with untreated fractions. ELISA was carried out 
as described. 
Analysis of mAb/antigen interactions Qy equilibrium dialysis 
The affinity and valence of the mAb for SCM antigens was de-
termined by equilibrium dialysis. 
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The mAb/antigen interaction under study is that involving a 
multivalent antibody and antigens of unknown, possibly multiple va-
lence. Thus, the following theoretical considerations apply to the 
analysis of the interaction between an antibody of valence n and 
antigen of valences (Hardie and van Regenmortel, 1975). Let 
A = total antigen concentration, moles/liter 
s antigen valence 
sA = total number of antigen binding sites, mole sites/liter 
B total antibody concentration, moles/liter 
n = antibody valence 
nB = total number of antibody binding sites, mole sites/liter 
y = bound antibody concentration 
x = bound antigen concentration 
At equilibrium the total number of occupied antibody sites (ny) 
is equal to the total number of bound antigen sites (sA). 
That is, ny = sx or x = ny/s 
Thus the free antigen (mole sites/liter) is 
sA - sx· = sA - ny 
and the free antibody (mole sites/liter) is 
nB - ny = nB - SX 
Under equilibrium conditions 
(sA - sx) + (nB - sx) ( 1) 
By the law of mass action 
SX ( 2) 
(sA - sx)(nB - sy) 
or n 
(sA - ny)(nB - ny) (3) 
Dividing (2) by B/B 
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Ka = sx/B x/B 
(SA - SX)(n - sx/B) (A - x)(n - sx/B) 
= r 
C(n-sr) where r x/B and C = A - x 
r/c = Ka(n-sr) ( 4) 
Equation (4) is the Scatchard form of the Law of Mass Action. From 
equation (4) the effect of antigen valence upon affinity can be 
seen. For the simplest case, antigen valence 1, the equation 
reduces to r/C = Ka(n - r). Plotting r /C yg. r over a range of 
antigen concentrations yields a straight line, giving the antibody 
valence n (intercept) and the Ka (slope) . But at low antigen 
concentrations, this line often deviates from linearity and curves 
toward the x -axis. Thus, interpolation of the line to obtain the 
value for antibody valence is error prone. For this reason, least 
squares non-linear regression analysis was performed using the 
software program Enzfit to fit the binding data to equation 5. The 
free unbound antigen (C) was plotted against the bound antigen (r = 
x/B) and the antibody valence and Kd (= l/Ka) calculated. 
r = nc 
Kd + C 
For a multivalent antigen (s>l) equation 5 becomes 
r = n/s (Cl 
Kd/s + C 
( 5) 
( 6) 
The least squares analysis yields n/s and Kd/s so that the antibody 
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valence and dissociation constant can not be determined without an 
independent estimation of the antigen valence, s. 
Equilibrium dialysis procedure. 
The time required to establish equilibrium for antigens alone 
was first determined. Several equilibrium dialysis cells were pre-
pared containing different concentrations of SCM antigens in borate-
buffered saline (BBS) , pH 8. 4. One side of the dialysis chamber 
containing 1 ml of antigen was separated by dialysis membrane (MW 
cutoff 10 kd) from the other chamber containing 1 ml BBS alone. The 
dialysis chambers had a volume greater than 1 ml and thus contained 
air bubbles to facilitate mixing. The chambers were maintained at 
37°c and equal volumes were removed from each side of the chambers 
at 0, 5, 10, 30, 60 m, then every 60 min for 8 h and at 18 h. 
Samples were frozen for determination of free antigen concentration 
as will be described in detail below. The time required for stable 
antigen concentration to be reached was used as the time for 
equilibrium in subsequent experiments. 
The antigens then were dialyzed ~· mAb. Various concentra-
tions of antigen were dialyzed against a constant concentration of 
mAb (2.5 x 10-6 M). Samples were removed from both sides at various 
time points and the free antigen concentrations determined at equi-
librium. 
To control for non-specific binding of the mAb, the antigens 
were dialyzed against TEPC (Sigma), an IgM myeloma. The equilibrium 
curve of antigens ~ buffer and vs TEPC could be compared to the 
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curves obtained with antigens ~· mAb to show that the equilibrium 
of the antigens was specifically affected by the mAb. 
To control for antigen specificity of the anti-SCM mAb, apro-
tinin (Sigma), MW 6,500, was dialyzed ~· the mAb and ~· buffer. 
The equilibrium curves were compared to determine the effect of the 
mAb on the equilibrium of a similar-sized but unrelated antigen. 
Aprotinin concentrations were determined from standard curves 
obtained by reading the absorption of various concentrations at 278 
nm in a Gilford spectrophotometer. 
Determination of free antigen concentrations for equilibrium 
dialysis 
Free SCM antigen concentrations were determined by a sandwich 
ELISA employing solid-phase rabbit anti-SCM antibody as the 
capturing antibody and the anti-SCM mAb to detect captured antigens. 
Rabbit anti-SCM 1: 100 in PBS was coated on 96-well ELISA plates 
(Falcon) 100 ul/well for 2 h at 22°c. The well supernatants were re-
moved and saved for further coatings. Various dilutions of SCM 
antigens were added (10- 5 to 10-8 M) to the wells and incubated 1 h 
22°c to obtain a standard curve. The equilibrium dialysis samples 
were added to the wells in the same volume as the standards. After 
incubation, the plates were washed 10 times with PBS containing 0.03 
% Tween-20. The mAb 1:5000 was added 100 ul/well and incubated 1 h 
at 22°c. The plates were washed and horseradish peroxidase-
conjugated goat anti-mouse IgM (Hyclone) 1:10,000 in PBS was added 
100 ul/well for 1 h at 22°c. The plates were washed and the sub-
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strata was added and plates read as described in "Enzyme-linked im-
munosorbant assays". The free antigen concentrations in the equi-
libriwn dialysis samples were determined by examining the optical 
densities obtained with the known concentrations of the antigens. 
To determine that the solid-phase rabbit anti-SCM was not 
binding the anti-SCM mAb or the goat anti-mouse IgM, the plates with 
solid-phase rabbit anti-SCM were incubated with these antibodies but 
without antigen. 
Amino acid analysis 
Antigens were subjected to acid hydrolysis and amino acid 
analysis using the Beckman System 6300 High Performance Analyzer 
with the Na-buffer ion exchange column (Beckman) . Samples were 
hydrolyzed in evacuated N2-flushed test tubes containing 0.3 ml of 
5.7 M constant boiling HCl, at ll0°c for 4-6 h. Typically, 20 to 
100 ug protein samples were hydrolyzed. After hydrolysis, tubes 
were opened and the contents dried over NaOH in a vacuum dessicator. 
Samples were solubilized in Na-s sample buffer (Beckman). Raw data 
was reported as nmoles amino acid/ml from which the minimal 
molecular weights and number of each amino acid residue was 
calculated. The nmoles of each amino acid recovered in an analysis 
was multiplied by the respective residue molecular weight to 
calculate the ng of the recovered amino acid. The residue molecular 
weight is equal to the molecular weight of the amino acid minus 18 
(molecular weight of one molecule water). The g of each amino acid 
residue per 100 g protein was then calculated. A minimum molecular 
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weight ( MMW) for the protein was <:hen calculated based upon these 
·,ralues: 
MMW amino acid residue molecular weight 
% amino acid residue in protein 
x 100 
The moles of each amino acid residue per 100 g protein was then 
calculated. The mole ratio (MR) was calculated as follows: 
MR = moles of residue per 100 g protein 
moles of residue present in smallest amount 
Corrected minimum molecular weights (CMMW) were then calculated 
based upon each amino acid: 
CMMW = (MMW) (MR) 
RESULTS 
Monoclonal antibody 
Analysis of ascites revealed that the mAb was IgM. Two ap-
proaches were undertaken to purify the mAb from ascites. The first 
was by affinity chromatography using two different columns 
(Reactigel and CNBr-Sepharose) containing SCM polypeptides. 
Ascites was loaded on each column. Recorder tracings (record-
ing absorption at 278 nm) showed that acid washes did not elute 
material from the Reactigel column while acid washes of the CNBr-
Sepharose column eluted material in amounts directly related to the 
volume of ascites loaded (Figure l). IgM was detected in the ef-
fluents of both columns. Though 88 ug/ml protein was detected in the 
eluent of the CNBr-Sepharose column, mAb activity was recovered only 
in the effluents of both columns. 
Purification of mAb by affinity chromatography was not effi-
cient and did not yield active mAb. For these reasons, euglobulin 
precipitation of IgM mAb from ascites was undertaken. Cellulose 
acetate electrophoresis of the starting ascites, the supernatant of 
the euglobulin precipitate, and the euglobulin precipitate showed 
that ascites IDS contained the typical serum profile with albumin, 
al, a2, P1, P2, and T proteins with a strong immunoglobulin band due 
to high concentration of mAb. The supernatant showed all serum 
proteins except the immunoglobulin band. The precipitate showed a 
strong immunoglobulin band and no albumin or other detectable 
ascites proteins. The precipitate was subject to SOS-PAGE followed 
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by silver staining to assess the purity of the precipitate by a more 
sensitive technique. The reducing gel revealed one band at 65-
70,000 Mr and one at 25-28,000 Mr, corresponding to the Mr of the 
heavy and light chains of IgM (Figure 2). Therefore this 
purification scheme produces purified IgM mAb essentially free of 
albumin and other mouse ascites proteins. 
Anti-SCM activity was recovered only in the precipitates and 
was absent in the supernatants (Figure 3). 
mAb retained anti-SCM activity. 
Therefore the purified 
The concentration of IgM was 2. 21 mg/ml as determined using 
goat anti-mouse IgM antibody. This agreed with the BCA protein 
assay which showed the concentration of protein to be 2 .10 mg/ml. 
These results further establish the purity of the IgM mAb. 
Basement membrane 
Microscopic examination of this sediment confirmed the presence 
of glomeruli free from cellular debris. This observation is 
consistent with the results obtained by Carlson et al. ( 1978) and 
Lange ( 1980a). 
The efficiency of trypsin digestion of murine GBM was 
determined by measuring soluble protein in the supernatants of the 
reaction. Efficiency was of GBM digestion was 79-99% (Table I) • 
Human lung and kidney BM also proved highly soluble with trypsin. 
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Figure l. Attempt at purification of mAb on SCM-Sepharose column. 
CNBr-activated Sepharose was coupled with SCM. Different volumes of 
ascites were loaded on this column, and the bound material eluted 
with Glycine-HCl, pH 2.0. 
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Figure 2. SOS-PAGE evaluation of purified IgM mAb. Lane 1: mol. wt 
standards. Lane 2: euglobulin precipitate. 
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Figure 3. Anti-SCM activity of the euglobulin precipitate. The IgM 
precipitate was resuspended in the original volume and its 
reactivity compared to that of the starting ascites and the 
euglobulin supernatant. Each bar represents the mean and standard 
deviation of three determinations. 
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TABLE I. YIELD OF SOLUBLE BM ANTIGEN 
Tissue Age % BM Digested 
by trypsin 
Murine kidney Day 1 99 
Day 5 97 
Day 10 94 
Day 15 79 
Adult 89 
Human kidney Adult 80 
Human lung Adult 80 
GBM or LBM was isolated from the tissues in-
dicated and digested with trypsin. The per 
cent BM solubilized by trypsin is indicated. 
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Streptococcal cell membrane 
Differential centrifugation was used to separate whole cells, 
debris and wall from membrane (Table II). Microscopic examination 
revealed that centrifugation at 3000xg pelleted most of the whole 
cells and some wall material. The supernatant from this was then 
centrifuged at 4500xg to remove the remaining wall material. The 
resulting supernatant was centrifuged at 24,SOOxg to pellet the mem-
brane. Gram stain and wet mounts of this pellet showed no evidence 
of wall material. To confirm that the membrane pellet was wall-
free, the membrane preparation was assessed for the presence of 
rhamnose and M 12 protein. 
SCM prepared by this method did not inhibit anti-M 12 antisera 
from binding M 12-coated ELISA plates (Figure 4). The SCM prepara-
tion was 0.07\ rhamnose, within the accepted limits for wall-free 
streptococcal membrane (Freimer, 1963). 
SCM extracted with SOS or digested with trypsin yielded anti-
gens reactive with purified anti-SCM mAb as determined by 
immunoblotting (Table III). 
yield reactive antigens. 
Extraction with Triton-X 100 did not 
Isolation of membrane antigens ~ affinity chromatography 
Previous work from this laboratory (Fitzsimons et al. 1987) 
showed that SCM and GBM shared common immunologic determinants. 
This was demonstrated when Fitzsimons et al. ( 1987) prepared mAb 
against SCM which was cross-reactive with GBM. One aim of the 
present work was to isolate SCM antigens using this mAb. 
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TABLE II. PREPARATION OF STREPTOCOCCAL CELL MEMBRANE 
Pellet Phase Microsc. Gram stain Rhamnose, % 
3000xg WHOLE CELLS POSITIVE n.d. 
(whole cells) 
4500xg DEBRIS POS. & NEG. 3.0 
(wall) 
24,SOOxg DEBRIS NEGATIVE 0.07 
(membrane} 
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Figure 4. Assay for the presence of M 12 protein in SCM. SCM and 
Ml2 were incubated with rabbit anti-Ml2 antibody 1 hr 37°c followed 
by 18 hr 4°. The supernatants were transferred to Ml2-coated ELISA 
plates. Points represent the mean and standard deviation of three 
determinations. 
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Figure 5. Determination of the rhamnose content of purified SCM. 
Rhamnose standards were used to determine SCM rhamnose content as 
described in Methods. The best fit was drawn through points 
representing single determinations. 
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TABLE III IMMUNOBLOT ANALYSIS OF SOLUBLE SCM ANTIGENS 
mAb Trypsin EDTA SDS SDS/CNBr Triton-X 
IDS 3+ 0 4+ 2+ 1+ 
Antigens extracted as indicated were blotted onto nitro-
cellulose at 10 mg/ml and probed with mAb 1:1000. Reacti-
vity (substrate color development) is rated 0 to 4+. 
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Three mAb columns were prepared as described. Each column 
bound 31, 25, or 22 mg IgM (Table IV). These columns were assessed 
for specificity by loading various related and unrelated proteins. 
All BSA, MSA, M48 loaded could be accounted for in the effluent of 
the column (Table V). Further, amino acid analysis of the M48 
eluate showed it to contain no protein, confirming that nonspecific 
binding to the mAb column did not occur (and suggesting that it was 
unlikely that mAb was being eluted by acid). Finally Ml2 protein 
was loaded on the column and the effluent and eluate assayed for the 
presence of Ml2 using rabbit anti-Ml2 antisera in ELISA. The 
reactivity of the effluent (concentrated to same volume as Ml2 
sample loaded) was similar to the reactivity of Ml2 loaded; no Ml2 
was detected in the eluate (Figure 6) • These results confirm the 
specificity of the mAb and the affinity column. 
The affinity column selectively bound from SDS-SCM and tryp-
sinized SCM, GBM, LBM antigens of 20, 13, 11.2, 10 kd, respectively 
(Figure 7). From the molecular size and amount of the antigens 
bound from the tryptic digests and the amount of mAb coupled to the 
columns, the antigen/mAb molar combining ratios were calculated 
(Table VI). The antigen/mAb combining ratios varied for each anti-
gen and were 2:1, 1:1, 3:1 for SCM, GBM, LBM, respectively. The 
antigen: antibody ratio was not determined for the SOS-extracted SCM 
antigen. 
Because only one antigen was bound from each fairly complicated 
digest, trypsin-digested SCM was further fractionated by HPLC to 
determine whether the membrane contains additional antigens. In-
TABLE IV. COUPLING OF mAb TO TRESYL-ACTIVATED COLUMN FOR AFFINITY 
CHROMATOGRAPHY 
A.U. on ml on mg on A.U. off ml off mg off mg bound 
COL 1. 1. 30 25.00 25.00 0.031 25.00 0.60 24.40 
1.30 9.00 9.00 0.380 9.00 2.60 6.40 
0.38 9.00 2.60 0.380 9.00 2.60 0 
TOTAL BOUND 30.80 
COL 2. 3.10 12.00 28.60 0.150 29.00 3.35 25.25 
0.15 14.50 1. 67 0.150 14.50 1. 67 0 
TOTAL BOUND 25.25 
°' COL 3. 3.40 12.00 31. 20 0.600 20.00 9.20 22.00 *'" 
0.60 10.00 4.60 0.600 10.00 4.60 0 
TOTAL BOUND 22.00 
A.U. = absorbance units at 278 nm. IgM content determined from the 
absorption at 278 nm using extinction coefficient 1. 3 
TABLE V SPECIFICITY OF ANTI-SCM mAb AFFINITY COLUMN 
Samplea A.u. 0 On A.U. EFFLUENT A.U. ELUATE % IN EFFLUENT 
BSA RUN l. 0.400 0.405 0.000 100.00 
2. 0.320 0.300 0.000 100.00 
M 48 l. 0.750 1.000 0.000 100.00 
2. 0.375 0.464 0.000 100.00 
MSA l. 0.130 0.138 0.000 100.00 
2. 0.250 0.245 0.000 100.00 
()'I 
CH3COOH 1. o.ooo 0.000 0.000 ------ U1 
2. 0.000 0.000 0.000 ------
a Proteins, 1 mg/ml: BSA, bovine serum albumin; M48, Type 48 M protein; 
MSA, mouse serum albumin 
b Absorbance units = Absorbance at 278 nm x ml 
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Figure 6. Specificity of anti-SCM mAb-coupled affinity column. Ml2 
was loaded and the effluent and eluate collected. These were 
concentrated, resuspended in the volume originally loaded, and 
coated on ELISA plates. Rabbit anti-Ml2 antibody was used to detect 
the presence of Ml2. Points represent the mean and standard 
deviation of three determinations. 
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Figure 7. HPLC-affinity chromatography of membrane preparations. 
A: HPLC-affinity chromatographic preparation of antigens from 
trypsin-soluble SCM. B-E: HPLC-sizing of SLS-soluble SCM eluate 
(B), trypsin-soluble SCM (C), GBM eluate (D), LBM eluate (E). 
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Reactivity of SCM polypeptides with mAb in ELISA 
To assess the reactivity of low MW SCM fractions which were not 
bound by the affinity column, ELISA microtiter plates were coated 
with 11.6, 9.2, 7.0, 4.7, 2.3 kd antigens at known concentrations. 
The plates bound approximately 90% of the protein at the coating 
concentrations employed (Table VII). First, the reactivity of each 
antigen was determined and shown to be proportional to the amount of 
antigen coated on the plate. Of interest, however, was the finding 
that equal ug amounts of these different size fractions gave similar 
reactivities with the mAb as judged by similar optical densities 
(Figure 10) • Since the reactivity was proportional to antigen 
concentration and because equivalent reactivity occurred for equal 
amounts of different size antigens, it follows that these antigens 
differed in their molar reactivities. That is, reactivity of each 
antigen seemed to be directly related to antigen molecular size. 
Unfractionated trypsin-digested SCM, from which these polypeptides 
were derived, exhibited significantly higher reactivity in ELISA 
when present in the same ug amount as the individual polypeptides 
(Figure 10) • 
Important for interpretation of these results is the specifi-
city of the mAb in the system. Specificity of the mAb for solid-
phase antigen was tested on plates coated with a variety of 
antigens: lyophilized, heat-killed whole M-type 12 cells (from which 
SCM was derived), M-type 12 cell walls, M-type 14 whole cells, oval-
bumin, and SCM from nontypable group A streptococci (Figure 11). 
The mAb showed significant reactivity in ELISA only with SCM anti-
71 
gens; the mAb was relatively non-reactive with the related bacterial 
antigens and the unrelated protein ovalbumin (Figure 11). The mAb 
was also reactive with the nontypable SCM, indicating that the 
membranes from these strains share antigens, although these antigens 
appear to be at different concentrations or densities. This result 
also shows that the mAb does not recognize M protein determinants 
since mAb binds trypsin-digested membrane from the nontypable 
strain. 
Affinity chromatographic analysis of SCM polypeptide antigens 
These antigens were reactive with mAb in ELISA but were not 
detected in eluates of affinity chromatography (only a 13 kd antigen 
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Figure 8. HPLC profile of SCM tryptic digest. SCM tryptic digest 
was passed over the Zorbax gel filtration column and individual 
peaks sized and collected. 
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Figure 9. HPLC-purification of SCM polypeptide antigens. SCM 
t.::yptic digest was passed over GF-250 gel filtration column and 
£:-actions of mol. wt 11.6 (A), 9.2 (3), 7.0 (C), 4.7 (D), and 2.3 
(~) purified by several rounds of recycling. 
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TABLE VII. ELISA MICROTITER PLATE-BINDING EFFICIENCY OF SCM 
POLYPEPTIDES 
Protein, MW Sensitizing Per cent Bound 
Concentration, uglml 
9,200 20 >90 
10 >90 
5 85 
7,000 20 >90 
10 >90 
5 75 
4,700 20 >90 
10 >90 
5 81 
2,300 20 >90 
10 >90 
5 75 
Each antigen was coated on the plates at the indicated 
concentrations and the amount of protein remaining in the 
supernatant measured by BCA to calculate the per cent bound 
to the plate. 
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Figure 10. Reactivity of E?LC-purified SCM polypeptide antigens. 
Equal ug amounts of SCM and each size fraction were coated onto 
ELISA plates and their reac~ivities with the mAb (1:8000) compared. 
Each bar represents the mea~ and standard deviation of three 
determinations. 
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Figure 11. SCM from grcup A nontypeable SCM was isolated as 
described for SCM. ELISA plates were coated with 5 ug/ml eac~ 
control antigen indicated and assayed for reactivity with mAb. 
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from trypsin digest and 20 kd from SDS-SCM were detected). However, 
each antigen did bind the affinity column when applied individually 
(Table VIII). The percent antigen in the eluate (the percent bound) 
for different amounts of antigen loaded was calculated; this number 
represents the efficiency of binding at different antigen concentra-
tions loaded. The maximum efficiency for each antigen was achieved 
when approximately 40 ug of the antigen was loaded (Table VIII). Of 
interest, the maximum efficiency of antigen binding (43 - 90%) was 
directly related to antigen size (Table VIII). These binding char-
acteristics are consistent with the size-related reactivities 
obtained by ELISA (Figure 10). 
It is possible that the size-related binding efficiencies in 
affinity chromatography were due to size-dependent stability of con-
formational epitopes. Another possibility is that the binding cha-
racteristics simply reflected differences in the number of epitopes 
per unit antigen. The binding characteristics of these antigens in 
ELISA and in affinity chromatography are consistent with the inter-
pretation that these antigens do vary in their number of epitopes 
available for mAb binding. 
The use of solid phase antigens in ELISA introduces some vari-
ables which may affect the outcome of the experiments. Although the 
efficiency of antigen binding to the plates is high, ·the amount ac-
tually bound varies slightly and may affect the interpretation of 
the mAb binding results. In addition, the orientation of the antigen 
when bound to the plate may affect the accessibility of epitopes. 
Likewise, affinity chromatography utilizes immobilized mAb, which 
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TABLE VIII. BINDING OF SCM ANTIGENS TO mAb COLUMN 
MOL. WT, kd nM LOADEDa nM BOUND \ BOUNDb 
11.2 3.5 
9.2 4.3 
7.0 5.4 
4.7 8.1 
2.3 17.3 
3.2 
3.7 
3.8 
4.4 
7.4 
91 
86 
71 
55 
43 
a Each peptide was HPLC-purif ied and 40 ug loaded. 
From the molecular weights the nanomoles loaded was cal-
culated. 
b The \ bound was determined by measuring protein in the 
eluates with BCA and by comparing areas under the curves 
of the effluents and the eluates. Amount bound is the 
average of several experiments. 
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may affect optimal mAb/antigen interactions. In an attempt to 
overcome these potential problems, a liquid phase inhibition assay 
was designed in order to examine the antigen/antibody interactions. 
competitive inhibition of mAb by SCM antigens 
The ability of the SCM antigens to absorb mAb was compared by 
competitive inhibition ELISA. Two different methods of competitive 
inhibition were used. In the first, designated the direct inhibition 
assay, different concentrations of SCM antigens were incubated with 
mAb for 1 h at 37°c followed by 18 h at 4°c. The mixture then was 
transferred to SCM-coated ELISA plates to assay mAb reactivity. In 
the second method, termed Clq-enhanced inhibition, the mAb was in-
cubated with various concentrations of SCM antigens at 37°c in Clq-
coated ELISA plates so that inhibitor-bound mAb would be selectively 
removed during incubation. Individual well supernatants· were removed 
and tested for reactivity for SCM-coated plates. 
Inhibition by the SCM antigens in the direct inhibition assay 
never exceeded 50% even at antigen concentrations in great excess 
(Figure 12A). If the mAb had a relatively low affinity for the li-
quid-phase inhibitor, mAb/Ag-inhibitor complexes may have easily 
dissociated due to higher affinity mAb binding to the solid-phase 
SCM antigens. To overcome this potential problem, the inhibition 
was performed in Clq-coated plates in order to selectively remove 
mAb/inhibitor complexes as they formed. 
The binding of solid-phase Clq to free mAb (no antigen added) 
was measured and found to be negligible (Figure 13). Inhibition 
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performed in the presence of Clq was consistent and reached higher 
levels than when performed without Clq. Type 12 M protein, a strep-
tococcal wall-derived antigen, did not inhibit the mAb (Figure 128). 
The inhibition curve for each antigen shifted to higher antigen con-
concentrations as the size of the SCM antigen decreased: the amount 
required for 50% inhibition of mAb was 0.30, 10, 40, and 110 pmoles 
for the 9.2, 1.0, 4.7, and 2.3 kd antigens, respectively (Figure 
128). These results are consistent with those obtained from direct 
ELISA (Figure 10) and affinity chromatography (Table VIII) which 
suggested that mAb binding was directly related to antigen size. Of 
note, relatively low concentrations of the 9.2 and 7.0 kd antigens 
achieved relatively high levels ( 20 - 40%) of inhibition, while 
similar concentrations of the 4. 7 and 2. 3 kd antigens had little 
effect on the mAb (Figure 128). These high levels of inhibition by 
the larger antigens were not observed for non-Clq inhibition. Clq 
in this system may stabilize mAb/inhibitor interactions or bind with 
higher affinity IgM mAb complexed with multivalent antigens. 
Inhibition was specific as described above using the M12 pro-
tein as a negative control. Cross-reactivity was confirmed by per-
forming inhibition with low MW G8M polypeptide fraction (Figure 14). 
As little as 1 ng inhibitor produced over 90% inhibition of mAb ac-
tivity. 
Collectively, these results show that the SCM polypeptide anti-
gens vary with molecular size in their reactivity with mAb: in-
creasing antigen size was associated with increased mAb column bind-
ing; equal amounts of different size solid-phase antigens showed 
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Figure 12. Competitive inhibition of mAb by SCM antigens. A) SCM 
antigens were incubated with mAb 1 h 37°c as described in Methods. 
Supernatants were transferred to SCM-coated plates to assay mAb 
activity. The percent inhibition is the mean of three experiments. 
B) Clq-enhanced inhibition was perfo::;ned by incubating the SCM 
antigens and mAb in Clq-coated plates. The supernatants were then 
transferred to SCM-coated plates to assay mAb activity. The results 
are the mean and standard deviation of three experiments. 
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Figure 13. Measurement of free mAb binding to Clq-coated ELISA 
plates. mAb was incubated in Clq-coated wells and transferred to 
SCM-coated wells. Points represent the mean and standard deviation 
of three determinations. 
c 
c 
' I 
i 
0.400 l 
I 
' 
0 . .300 l 
I 
0.20C ..!... 
I 
I 
88 
0. 1 00 .,....1--....-------'---------_,_~.,..............,.....:----.-
2CCO 1 ::4- 1 ES 
INVERSE G!LUTlON mAb 
89 
Figure 14. Competitive i~hibition of mAb by low mol. wt GBM 
antigen. A 5 kd HPLC-pu~i!ied GBM fraction was incubated with 
different dilutions of mr.b l hr 37°c and 18 hr 4°. Supernatants 
were transferred to SCM-c=a~ed plates to assay mAb activity. Points 
represent the mean and standard deviation of three determinations. 
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antigen size. Whatever the structural basis may be for the differen-
ces in reactivity with mAb, these differences might be expected to 
be manifested in the experimentally determined functional affinity 
of the mAb/antigen interaction. 
Affinity .QI. mAb for SCM polypeptide antigens 
Several observations prompted an investigation into the af-
finity of interaction between the SCM antigens and the mAb. First, 
the antigens showed a size-dependent ability to inhibit the mAb; the 
amount required for inhibition increased with decreasing antigen 
size. Second, the mAb affinity column bound from the complete tryp-
tic digest only a 13 kd antigen, yet the 11.2, 9.2, 7.0, 4.7, 2.3 kd 
SCM antigens each were reactive in ELISA. Finally, the SCM antigens 
each did bind the mAb column when applied alone, but the efficiency 
of binding decreased with decreasing antigen size. To determine 
whether these observations, particularly the differences in mAb col-
umn binding efficiencies, were due to differences in mAb affinity 
for these antigens, two different procedures were employed to 
measure mAb affinity. First, the ability of these antigens to 
compete for binding to the mAb column was measured. In this 
experiment, the ability of each size antigen to elute or displace 
other size antigens was determined. Second, a more direct measure of 
mAb affinity was obtained by equilibrium dialysis of mAb .Y.§.. each 
antigen. 
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Figure 15. Competitive bi'-~ing of SCM antigens to mAb column. Each 
antigen was loaded with re~eated injections as indicated in (A) 
until column was satura~ec. The effluent from each was analyzed by 
HPLC gel filtration. T~e e::luent of the 2.3 (3), 4.7 (C), 7.0 (D), 
9.2 (E), 13 .. 0 kd (F), a~d acid wash (G) are shown and the components 
identified. 
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Competition of SCM antigens in affinity chromatography 
If the results of affinity chromatography (only 13 kd bound 
from tryptic digest) were due to high mAb affinity for the larger 
antigens, then the low MW antigens may have been displaced from mAb 
by the largest antigen. To address this problem, the ability of each 
antigen to displace smaller antigens from the affinity column was 
measured. First, the 2.3 kd antigen was loaded on the column and 
recycled until the column was saturated. The effluent was collected 
and the 4.7 kd antigen was added to elute the 2.3 kd antigen. The 
flowthrough was collected and the 4. 7 kd added in an attempt to 
saturate the column. This was repeated with the 7. 0, 9. 2, 13 kd 
antigens, after which the column was washed with acid. The 
effluents and the acid wash each were analyzed by HPLC gel filtra-
tion to determine the size of the components eluted (Figure 15). 
When the column was saturated with the 2. 3 kd, the effluents 
contained the 2.3 kd, as expected. Attempts to saturate with the 
4. 7 kd resulted in only some 2.3 kd appearing in the effluent. 
Following with the 7.0 kd, again saturation could not be achieved, 
as only 2.3 kd was detected in the effluents. Loading the 9.2 kd 
eluted 2.3 and 4.7 kd, but the effluents never contained 9.2 kd. 
Finally, the 13 kd was loaded. 
4.7, 7.0 kd (Figure 15). 
Its effluents contained only 2.3, 
It is difficult to interpret the results of this series of 
experiments. Evidence suggests that the column did not reach 
saturation with any (except 2. 3 kd) of the antigens. Following 
saturation of the column with 2. 3 kd, the behavior of the other 
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antigens was unpredictable and inconsistent. Apparently, once 
saturated, the column did not readily bind the larger antigens. 
Addition of the larger antigens resulted not in total displacement 
of the smaller, but in only incremental and incomplete displacement. 
Thus, if the previously bound antigens were never completely eluted 
by larger antigens, the result would be what was observed: inability 
to saturate the column with the larger antigens. Therefore, the 
displacements that occurred can not be used to quantitate affinities 
for the mAb. 
Equilibrium dialysis of mAb and SCM antigens 
Equilibrium dialysis of SCM antigens Y§.. buffer, mAb, and TEPC 
was performed to establish equilibrium conditions for the antigens 
alone and to show that the mAb had a specific effect on the equi-
librium of the antigens. Figure 16 shows that equilibrium was 
reached by 3 h at 37°c in all cases. At equilibrium the antigen con-
centration on its side of the chamber was lowered only when dialyzed 
Y§.· mAb. Varying antigen concentrations then were dialyzed Y§.. mAb 
(2.5 x 10-6 M) and the free and bound antigen concentrations at 
equilibrium determined. Free antigen concentration was plotted vs. 
bound antigen concentration (Figure 17). Non-linear least squares 
regression analysis of the binding data calculated the mAb capacity 
and Kd for each mAb/Ag interaction. 
It appears that mAb was saturated only when dialyzed Y§.. 9.2 kd 
antigen (Table IX). The mAb reached only 40% saturation with the 
7.0 kd antigen and much lower with the 4.7 and 2.3 kd antigens. 
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Figure 16. Equilibrium dialysis of SCM antigens. SCM antigens were 
dialyzed Y..§.. buffer, mAb, er TEPC a~ 37°c. Antigen concentrations 
were determined on rabbit anti-SCM plates as described. Points 
represent the mean of at ~east three determinations. 
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Figure 17. Nonlinear leas~ squares regression plots of binding data 
obtained by equilibrium dialysis. Antigen at different 
concentrations was dialyzed against a constant amount of mAb. At 
equilibrium the free and bound antigen concentrations were 
de~ermined as described in Methods. 
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TABLE IX. MONOCLONAL ANTIBODY AFFINITY AND VALENCE FOR SCM ANTIGENS 
Ag, kD mAb CAPACITYa mAb VALENCEa SLOPE a Kd ml-l %SATURATION 
{Moles) OF mAb 
9.2 4.69 x 10-6 2 ± 0.1 0.029 1. 39 x 10-1 90 
7.0 1. 59 x 10-5 6 ± 5 0.383 6.08 x 10-6 40 
4.7 n.d. 1ob 0.462 3.83 X 10-6C 8 
2.3 n.d. 1ob 0.153 1.15 x 10-5c 1. 2 
a. Slope and capacity were calculated from plots of the binding data. 
Valence is defined as the capacity (max (Ag) bound divided by (mAb]). 
b. Since the slope remains constant for the 4.7 and 2.3 kD antigens, 
but the per cent saturation decreases, Kd must increase and thus the 
capacity (valence) must also increase, likely approaching 10. See text. 
c. Kd can not be determined as it was not possible to saturate the avail-
able antigen combining sites at the antigen concentrations available. 
Thus the values of Kd presented for the 4.7 kd and 2.3 kd antigens were 
calculated assuming a mAb valence of 10. 
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This degree of saturation places limitations on the 
interpretation of mAb valence and Kd. Because the mAb was saturated 
only in the case of the 9.2 kd antigen, mAb valence could be confi-
dently measured only for this antigen. The valence of 2 agreed with 
the Ag:mAb combining ratio on the affinity column for the 13 kd 
antigen (Table VI). Although a direct measurement of valence cannot 
be derived with confidence for the two smallest antigens, it can be 
seen that the valence must increase for these smaller antigens. The 
slope remains constant for the 7.0, 4.7, and 2.3 kd antigens. Slope 
is defined as ~/mAb capacity; since the slope is constant but Kd 
increases, the mAb capacity (valence) must also increase. 
The affinity (l/~) of the mAb for these antigens was directly 
related to antigen size (Table IX). In the case of the 2.3 kd anti-
gen, it is not clear whether an accurate Kd can be derived from the 
binding data since the mAb was so far from saturation. These 
results show an increase in affinity of the mAb for the larger 
antigens and suggests that the mAb valence may also be directly 
related to antigen size and observed reactivity. 
Comparison of native and denatured SCM antigens 
The antigen reactivity and size were found to be related to 
affinity of mAb/antigen binding. These observations could be ex-
plained by differences among the antigens in the expression, acces-
sibility, or number of epitopes. The differences in mAb binding 
could be the result of a size-dependent stability of antigenic con-
formations. Instead, the size-related differences in mAb binding 
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TABLE X. REACTIVITY OF NATIVE AND DENATURED SCM ANTIGENS WITH 
mAb in JiiJ;iISA 
Antigen Optical density, 405 nm ± S.D. o.o. Increase 
Native Denatured 
13 kd 0.236 ± 0.026 0.270 ± 0.027 0.034 
11.2 kd 0.092 ± 0.020 0.348 ± 0.042 0.256 
9.2 kd 0.103 ± 0.050 0.320 ± 0.050 0.217 
7.0 kd 0.109 ± 0.027 0.326 ± 0.020 0.217 
4.7 kd 0.108 ± 0.015 0.307 ± 0.023 0.199 
2.3 kd 0.103 ± 0.005 0.231 ± 0.037 0.128 
"Denatured" antigens were heated to boiling and coated on 
ELISA plates. The reactivity of these antigens with mAb was 
compared to untreated "native" antigens. 
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could be due to a repeating epitope in the amino acid sequence of 
these antigens. To distinguish between these two possibilities, 
that is, to test whether the epitope is defined by conformation or 
primary structure, SCM polypeptides derived from trypsin digest of 
SCM and the SCM antigen eluted from the affinity column each were 
subjected to heat denaturing conditions. Following boiling for 30 
min each antigen retained reactivity with mAb. The untreated 
and denatured 20 kd antigen showed nearly the same level of reac-
tivity (Table X). In contrast, the smaller SCM polypeptides 
achieved higher levels of reactivity after denaturing conditions 
(Table X). Of note, these antigens showed different responses to 
denaturing conditions: at antigen excess (antigen 5 ug/ml, mAb 0.25 
ug/ml), the increase in reactivity was directly related to antigen 
size (Table X). 
The epitope may be defined by amino acid sequence since heat 
denaturing conditions did not destroy the reactivity of these 
antigens. In fact, these antigens became more reactive following 
heat denaturation, suggesting that additional sequence-determined 
epitopes may become accessible after inter- and intra-peptide 
associations are disrupted. 
Amino acid analysis 
Amino acid analysis of these antigens was performed to deter-
mine if amino acid compositions could be correlated with the size-
dependent reactivities. The amino acid analysis of each SCM antigen 
showed that the MW of each polypeptide as determined by amino acid 
TABLE XI. AMINO ACID ANALYSIS OF SCM ANTIGENS 
MOL WT NUMBER OF EACH AMINO ACID 
HPLC AAA B T s z p G A c v M I L y F H K R ACID:BASIC 
20 kd 18.9 kd 19 9 9 20 6 17 14 2 10 1 8 14 1 9 8 11 5 2.6 
13 kD 11.9 kD 13 6 5 13 4 11 9 1 6 1 5 9 2 4 4 7 3 2 
9200 9125 13 5 4 15 3 8 7 1 6 1 5 6 1 3 1 2 1 7 
7000 6998 11 4 3 9 2 7 6 1 5 1 4 5 1 2 1 2 1 5 
4700 4656 4 2 2 4 2 4 3 1 3 1 3 4 1 3 1 2 1 2 
~ 
2300 2334 2 1 1 1 1 2 1 1 1 0 1 1 0 3 1 1 1 1 
0 
~ 
Acid:basic values were determined by dividing the total number of Glu and Asp by 
the total number of Arg, Lys and His. Single letter amino acid symbols: B Asp or 
Asn, T Thr, s Ser, z Glu or Gln, p Pro, G Gly, A Ala, C Cys, V Val, M Met, I Ile, 
L Leu, Y Tyr, F Phe, H His, K Lys, R Arg 
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analysis correlated well with the MW obtained by HPLC gel filtration 
(Table XI). The nmoles/ml amino acid was reported for each antigen, 
from which the number of each amino acid per antigen was calculated 
(Table XI). From this analysis, it was clear that certain residues 
remained constant while other residues changed with changes in 
antigen size. All antigens contained one residue of Cys, Met, Tyr, 
His, and Arg except for the 2.3 kd antigen, which had no Met or Tyr. 
Each antigen had 3 Phe, except the 7.0 kd which had 2; each had 2 
Lys, while the 2.3 kd had only 1. In contrast, the residues Asp, 
Thr, Ser, Glu, Pro, Gly, Ala, Val, Ile and Leu each increased with 
increase in size of the antigens. Notably, acidic amino acids in-
creased in number the most with increase in antigen size, resulting 
in differences in relative acidity of these antigens (Table XI) 
which can be seen when the ratio of acidic to basic amino acids is 
calculated for each antigen. 
In these antigens, the number of acidic and aliphatic side 
chain amino acids was directly related to antigen size, reactivity 
and mAb affinity. Because evidence suggested that the epitope may 
be defined by amino acid sequence, one interpretation of the amino 
acid analyses is that these amino acids contribute to a linear 
epitope which repeats and thus is found in higher number in the 
larger antigens. 
Amino acid sequencing 
Several antigens were prepared by RP-HPLC or by SOS-PAGE and 
transfer to PVDF for amino acid sequencing. These results are sum-
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marized in Table XII. Antigens initially isolated by HPLC gel 
filtration (2.3 and 4.7 kd SCM polypeptide antigens) did not absorb 
to ca or c1a reverse-phase columns; nearly all the protein loaded 
appeared in the flowthrough with the phosphate salts. Different 
gradients did not change the absorption characteristics. The flowt-
hroughs from the above runs were desalted on GlO columns; this 
material was sequenced and found to consist of low MW materials 
suggesting that the antigens may have been degraded by attempts at 
purification. 
The 13 kd SCM antigen isolated by affinity chromatography and 
purified by gel filtration HPLC gave a single broad peak on the ca 
column. Recycling on c1a showed a variety of low MW peptides. One 
peak containing approximately 30 pmoles protein was sequenced. The 
sample was found to be degraded to several low MW peptides by the 
purification step; peptide in the sample appeared to be N-terminally 
blocked. To reduce the handling steps of this antigen, affinity 
isolated 13 kd SCM antigen was placed directly on c1a, ca, or C4 
columns. These resulted in single broad peaks, which sequencing 
determined also to be contaminated by low MW peptides and di- and 
tripeptides. 
Because the RP-HPLC buffers (acetonitrile and TFA) were sus-
pected to be causing sample destruction, samples were prepared by 
SDS-PAGE and electrotransfer to PVDF. A 20 kd SCM antigen and a 13-
15 kd SCM antigen were successfully transferred to PVDF in 
sufficient amounts for microsequencing. However, their sequences 
were not obtained due to N-terminal blocking of these polypeptides. 
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Finally, the 11 kd GBM antigen isolated by affinity chromatog-
raphy was applied to the C18 column; the resulting single broad peak 
was recycled and sequenced. This sample also appeared to have been 
destroyed and/or N-terminally blocked. 
As an internal control, ~-lactoglobulin was prepared by RP-HPLC 
or by SOS-PAGE and transfer to PVDF. Sequencing of both prepara-
tions gave appropriate amino acid sequences. 
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TABLE XII. SUl'.MAR:! OF A..'!!:ro ACID SEQUE11CING EXPER!XE!!TS. 
SAMPLE 
sex 2 .3 KD 
SC.'! 2. 3 KD 
sex 4. 7 KD 
sex 13 KD 
SCM 13 KD 
SCM 20 KD 
SCM 13-15 KD 
GBM 11 KD 
PROCE::URE RESULTS 
1. HPLC GEL ?rL:RATION (3 CYCLES) ••••••• SWGLE PEAK 
2. AFFINITY 3PLC (ANTI-SCM mAb COLUMN) •• 
3. RP-HPLC C3 ••••••••••••••••••••••••••• PROTEIN IN FLOilTHROUGH 
4. GlO CESALT::rG, SEQUENC!:IG .••••••••••• DI-, TRIPEl?T:DES: 
SAMPLE DEGRADATION 
l. HPLC GZL n:.:RATION •••••••••••••••••• sr:rGLE PEAK 
2. Rl?-HPLC CS OR Cla ••••.••••••••••••••• l?ROTEIN IN FLOilTHROUGH 
3. GlO DESAI.TrnG, SEQUENCWG •••••••••••• OI-,TRIPEPTIOES: 
SAMPLE OEGRACATIO!I 
l. Hl?LC GEL FILTRATION (3 CYCLES) ••••••• SI:IGLE PEAK 
2. Rl?-HPLC ca OR c1a •••••••••••••••••••• PROTEIN IN FLOWTF.ROUGH 
3. GlO DESAI.':'WG, SEQUENCING ••••••.••••• OI-,TRIPEPTIOES: 
SA..'!PLE DEGRADATION 
l. AFFINITY :>?LC (ANTI-SCM mAb COLUMN) •• 
2. HPLC GEL F!L':'RATION OF ELUATE •••••••• SINGLE PEAK, 13 KD 
3. RP-HPLC CS ••••••••••••••••••••••••••• SINGLE, BROAD PEAK 
4. Rl?-HPLC c:a OR C4 •••••••••••••••••••• MULT!PLE LOW MOL. ilT 
PEA..'<S 
5. SEQUE!ICE ONE PEAK (30 pM) •••••••••••• MIXEO/N-BLOCKEO 
l. AFFINITY !iPLC •••••••••••••••••••••••• 
2. RP-HPLC Cl8, ca OR C4 •••••••••••••••• SINGLE, BROAD PEAK 
3. SEQUE!ICI!IG ••••••••••••••••••••••••••• 0 I-, TRI PEPTIDES: 
SA..'!PLE DEGRADATION 
l. SOS-PAGE ?VDF MEMBRA!IE •.•••••.••••••• 
2. SEQUE!IC!!:G ••••••••••••••••••••••••••. N- 3L0Cl<EO 
l. SOS-PAGE PVDF MEMBRANE ••••••••••••••• 
2. SEQUE!ICI~IG ••••••••••••••••••••••••••• N-3LOCKEO 
1. AFFW!:'Y 3PLC (ANTI-SCM mAb COLUMN) •• 
2. HPLC GEL FILTRATION OF ELUATE •••••••• SINGLE PEAK, 11 KD 
3. RP-HP!.C c:a •••••••••••••••••••••••••• BROAD PEAK 
4. RECYC:.E Cl8, SEQUENc::::1G •.•••••••••••• or-' TRI PEPTIDES: 
SAMPLE DEGrtAOATION; N-3LOC:<ED 
,B-LACTOG:.OBULIN ' sos-?.".GE PVDF & SEQUENC!:IG ••••••••••• APPROPRIATE SEQUE:lCE 
CONTROL 2. RP-HP!:.C i SEQUENC::::lG •••••••.••••••••• APPROPRIATE SEQUE:ICS 
DISCUSSION 
The link between infection by specific group A streptococci and 
subsequent autoimmune disease has been described by several inves-
tigators (Futcher, 1940; Rammelkamp et gl. 1952; Stollerman, 1969; 
McLaren et al. 1975; Nissenson, 1979). Evidence has been presented 
which supports an autoimmune/molecular mimicry model for the 
etiology of post-streptococcal disease (Markowitz and Lange, 1964; 
Lange et al. 1985, 1986; Fitzsimons ~ al. 1987). In support of 
this hypothesis, nephritogenic antibodies have been developed which 
are specific for streptococcal membrane-derived proteins (Fitzsimons 
et al. 1987) • These proteins should share some immunochemical 
properties with the mammalian autoantigens, specifically with the 
GBM antigens recognized by anti-SCM antibody. As an initial step in 
characterizing the antigens in this autoimmune system, this 
dissertation describes the immunochemical properties of strep-
tococcal cell membrane protein antigens recognized by an anti-SCM 
mAb cross-reactive with GBM. The results have implications for the 
structure of the SCM antigens and the immunologically related BM 
autoantigens. Furthermore, a model for APSGN can be constructed 
which accomodates these new observations regarding the SCM antigens 
and the monoclonal antibody. 
Immunologically related antigens in SCM and BM 
One aim of these studies was to isolate SCM protein antigens 
using this IgM anti-SCM mAb. Isolation of specific antigens was ac-
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complished by affinity chromatography. Though several observations 
suggested that this anti-SCM IgM mAb bound its homologous antigen 
with relatively low affinity, affinity chromatographic isolation of 
immunologically related antigens was successful. Affinity isolation 
may have been facilitated by increased affinity associated with 
multivalent interactions between IgM and specific antigens (Hirayama 
et al. 1985; Poncet et al. 1988; Mallet et al. 1989). 
Because immobilized IgM would have multiple paratopes available 
for antigen binding, antigen:Ab molar combining ratios of at least 
1:1 were anticipated. The antigen:Ab combining ratios were 2:1 for 
SCM and 3:1 for LBM, but only 1:1 for GBM. Higher combining ratios 
were not observed possibly because of steric hindrance of paratopes. 
An alternative explanation is that multiple epitopes in each antigen 
occupied more than one paratope. The absolute number of epitopes 
for each antigen (antigen valences) cannot be determined from these 
data because antigen valence is a constant which is independent of 
the antigen:Ab combining ratios (Van Regenmortel, 1988). The 
relatively low antigen:Ab combining ratio for the GBM antigen may be 
due to masking of protein epitopes. GBM is composed of many glyco-
proteins with a-linked disaccharides and Asn N-linked heteropolysac-
charides consisting of galactose, mannose, hexosamines, sialic acids 
and fucose (Spiro, 1967). GBM has a high hydroxylysine content 
(Spiro, 1967; Lange, 1969; Lange et al. 1986) and as much as 70% of 
these residues are involved in the linkage of the disaccharide 
units. Thus, these carbohydrates may interfere with interaction of 
the mAb with protein epitopes in GBM (Blue and Lange, 1975). Since 
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these GBM samples were digested with trypsin and not with car-
bohydrase or collagenase, carbohydrate masking remains a 
possibility. 
Of note, each column bound only one major component from each 
membrane preparation (trypsin-digested SCM, GBM, LBM and SDS-solubl-
ized SCM). How does one explain the selection of a specific sized 
antigen from fairly complicated membrane trypsin digests which con-
tains smaller antigens? The concentration of the antigen in the 
digest certainly would affect the probability of its being selected. 
Though the absolute amount of each component in the digest is dif-
ficult to determine, from HPLC tracings of the SCM digest it appears 
that the larger fragments are a relatively higher proportion of the 
SCM trypsin digest. Another reason why predominantly one size 
antigen was bound from each digest could be related to the effect of 
antigen size on stability of epitopes. These antigens may be of the 
minimal size required to maintain an antigenic conformation which 
cannot be attained or stabilized in the smaller peptides from the 
digest (Sundaralingam et al. 1985; Gras-Masse et al. 1988). Larger 
antigens may have not been bound because of the restrictive environ-
ment of the column. That is, steric factors related to the column 
support material and the large size of IgM may permit only certain 
sized fragments to align and bind mAb with sufficient affinity (Ber-
gold et al. 1988; Frenz and Howath, 1988). As a result, the immobil-
ized IgM mAb may bind with higher affinity antigen having multiple 
epitopes or epitopes that are available due to the peptide's struc-
tural stability (Bergold et al. 1988; Frenz and Howath, 1988). 
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Support for the assertion that the antigenic peptides vary in 
their number of epitopes is the observation that mAb column-binding 
efficiencies of the tryptic SCM polypeptides when applied 
individually increased with increasing size. These observations 
suggest a mechanism by which the columns could selectively bind the 
larger antigens from the complete digest. competition of antigens 
for IgM would favor antigens with more epitopes because such 
antigens would favor multivalent interactions with mAb (Bergold et 
al. 1988; Frenz and Howath, 1988). Taken together these experiments 
suggest that differences in binding between these polypeptides oc-
curred, despite only small differences in size, because of dif,.. 
ferences in number or size-dependent stability of epitopes. 
SCM antigens exhibit size-dependent reactivity 
As described above, the SCM tryptic polypeptides not selec-
tively bound by the affinity columns did bind when applied in-
dividually, but at different efficiencies. These antigens showed 
size-dependent reactivity in other experiments also. The unexpected 
result of routine screening of the low MW SCM fractions was that 
equal microgram amounts of select sized antigens were equally reac-
tive in ELISA; their reactivities thus increased with size. 
A parameter essential to the interpretation of this ELISA is 
how much polypeptide antigen is actually bound to the microtiter 
wells. Variation in plate binding efficiency during the coating 
step could be expected to affect the interpretation of epitope den-
sities if it were determined that different polypeptides bound the 
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solid phase with different efficiencies. In solid phase assays the 
antigen concentration would seem difficult to determine since it can 
be expected that not all the antigen added to the system may ac-
tually bind to the solid phase. This ELISA used polypeptide con-
centrations of 2. 5-10 ug/ml. Within this range the polypeptides 
showed 90% binding to the plates. It is not uncommon for proteins 
in this concentration range to bind nearly completely to plastic 
(Pesce et al. 1977) since plastic binding is by non-specific 
electrostatic attraction. Naturally, as antigen concentration 
increases, the actual fraction bound will decrease. That each 
antigen showed similar percent binding at the concentrations emplo-
yed strengthens the argument that these polypeptides were present in 
equal amounts and thus differed in their molar reactivities with 
mAb. 
Another problem with solid phase assays is the availability of 
epitopes when antigens are bound to plastic. This presumably would 
affect the reactivity of the smaller SCM antigens more than the 
larger antigens, which potentially have more epitopes. To overcome 
this problem in interpreting the solid-phase ELISA a competitive 
inhibition assay was designed in which the interaction of antigen 
with mAb could be assayed in liquid phase. Two different inhibition 
assays were developed. Low levels of inhibition were achieved by 
each antigen using the first method (mAb + inhibitor lh 37°c, then 
1a h 4°c>. However, it was not possible to compare these antigens 
because of the relatively low levels of inhibition. It was .reasoned 
that the mAb had low affinity for the liquid phase inhibitors, 
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allowing displacement of the inhibitor by the solid phase antigens. 
The mAb may prefer the orientation the antigen assumes while bound 
to solid phase. Though the proteins are in equilibrium among various 
folded and unfolded states while in solution, the plastic bound 
orientation would be stable. Other investigators have reported mAb 
which preferentially bind protein antigens which are solid phase. 
Djavadi-Ohaniance and coworkers (Djavadi-Ohaniance et al. 1984 and 
Friguet et al. 1984) reported a population of mAbs which bind the P2 
subunit of Escherichia coli tryptophan synthase in solid phase but 
are unable to interact well with the protein in solution. Apparently 
this population of mAbs binds determinants which are exposed or 
stabilized when the protein is bound to plastic. 
The second assay utilizing solid phase Clq was developed to 
test whether solid-phase Clq could either enhance the stability of 
the mAb/inhibitor interaction or selectively remove inhibitor-bound 
antibody. Purified Clq (Yonemasu and Stroud, 1971) has been used in 
solid phase to detect circulating immune complexes (Hay g!;. al. 1976; 
Wahler et al. 1981; Singh and Tingle, 1982; James et al. 1983). 
Certain antibodies bound to multivalent antigens will bind Clq effi-
ciently (Brown and Koshland, 1975). Human IgG1 and IgG3 bind Clq 
strongly while IgG4 binds only very weakly (Augner et al. 1971). In 
the murine system, IgG2a binds Clq strongly (Leatherbarrow and Dwek, 
1984) while IgM from all species binds Clq efficiently. This assay 
exploits the ability of Clq to bind IgM complexed with antigen. 
The results clearly show the effect of antigen size on the amo-
unt required to inhibit mAb. Each antigen shows a dose~dependent 
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inhibition of mAb, but the 9.2 and 7.0 kd antigens cause relatively 
high levels of inhibition with relatively small amounts of antigen. 
This effect was not as extreme in the inhibition assay run without 
Clq. These results may be due to the unique interaction of Clq with 
IgM complexed with multivalent antigens. Swanson et al. ( 1988) 
showed the effect of antigen epitope density on the ability of Clq 
to bind IgM. Clq binding to IgM was significantly enhanced when IgM 
was complexed to multivalent antigens. Though IgM bound the 
different antigens with similar avidity, the binding of Clq to IgM 
was directly related to the epitope density of the antigens (Swanson 
§ g!., 1988). Their hypothesis was that Clq binding to IgM was 
enhanced because multivalent antigen binding caused a favorable 
conformational change in the Clq-binding region of IgM. Because the 
reactivity of the SCM antigens appeared to be related to molecular 
size, these antigens may vary in their number of epitopes. Thus 
larger 7.0 and 9.2 kd antigens with more epitopes would participate 
in multivalent IgM binding leading to efficient Clq binding. The 
net result would be more efficient removal of mAb when complexed to 
the higher epitope density antigens. Many more molecules of the 
smaller antigens would be required to reach similar levels of 
inhibition because their lower number of epitopes probably affects 
both mAb affinity and efficiency of Clq binding. 
To confirm the cross-reactivity of the mAb with GBM in the 
ELISA system, inhibition of ELISA was performed. Of interest, only 
one nanogram (20 pmoles) of the 5 kd GBM fraction was able to in-
hibit binding of 12.5 pmoles mAb to SCM. Theoretically 1 pmole IgM 
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should bind on average 5 pmoles antigen but these results suggest 
that efficient inhibition occurred with only two-fold antigen, since 
20 pmoles of the 5 kd fraction resulted in 95% inhibition of 12.S 
pmoles antibody. In general, inhibition is probably not just de-
pendent on paratope binding by the inhibiting antigen, but also on 
steric hindrance of unbound paratopes, so the size of the inhibitor 
is a critical factor. In a different study, Fitzsimons et al. 
( 1987) inhibited anti-SCM mAb binding to SCM with 1 ng unfrac-
tionated GBM digest. In contrast, the present study utilized a 
purified low MW antigen; thus, the level of inhibition achieved by 
this 5 kd fraction is significant since it probably reflects speci-
fie binding to the paratope. Furthermore, the high levels of 
inhibition achieved by only 2-fold 5 kd antigen may reflect the 
occupancy of multiple paratopes by single antigens. 
Monoclonal antibody affinity ~ valence ~ directly related to 
antigen size 
The relationship between antigen size and mAb binding was 
further investigated. Analysis of mAb/antigen interactions in af-
finity chromatography suggested that the antigens bound with dif-
ferent efficiencies. ELISA and competitive inhibition experiments 
further suggested that antigen size was directly related to reac-
tivity. The question arose whether the affinity of the mAb for each 
antigen was also related to antigen size. 
Equilibrium dialysis determined that mAb/antigen affinity and 
mAb valence indeed varied with the size of the antigens. -The non-
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linear least squares regression analysis plots yielded Kc! values 
varying from 10-S to 10-7 , within the range of affinities reported 
for the interaction of IgM with multivalent haptens or antigens 
(Chua ~ sJ,.. 1975; Huchet and Feldman, 1973; Makela and Kontiainen, 
1971; Makela et al. 1970). Of interest, affinities of the mAb for 
the antigens paralleled the increasing size and reactivities of 
these antigens. If these antigens do vary in their number of 
epitopes, it is possible that the increasing affinities are due to 
the the associated increased opportunities for multivalent 
interactions with mAb. Thus the observed functional affinity of IgM 
binding to antigen would be governed by the number of epitopes 
available. 
The pronounced effect of antigen valence upon antibody affinity 
were described first for the interaction of a divalent antibody with 
multivalent antigens (Singer and Campbell, 1952 and 1953). The 
relationship between the intrinsic association constant (K0 , 
affinity of individual antibody combining sites for single epitopes) 
and the observed functional affinity was described by the following 
relationship: 
KM = nK0 /2 
where KM is the observed association constant of the interaction 
between a divalent antibody molecule and an antigen molecule of n 
number of combining sites. From this relationship, it is clear that 
the valence of the antigen molecule may exert a significant effect 
upon the overall affinity of the interaction even though the average 
intrinsic association is of low magnitude. 
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In another study of the interaction of divalent antibody with 
multivalent antigens, Larsson (1989) found a "bonus effect" due to 
divalent antibody binding. In this model an increase in the number 
of epitopes caused an increase in antibody binding and affinity that 
was much more than proportional to changes in epitope number 
(Larsson, 1989). Thus, small increases in epitope number could pro-
duce significant increases in binding affinity. 
In studies of the interaction between IgM and multivalent 
antigens, the effect of multivalent binding upon functional affinity 
was also noted. It has been shown that the pentamer structure of IgM 
may confer a biologically active functional affinity even when the 
intrinsic affinity of individual combining sites is as low as 102 
(Ternynck and Avrameas, 1986; Karush, 1978). A higher functional 
affinity of pentameric IgM mAb specific for hen egg lysozyme (HEL) 
was demonstrated by Mallet et al. (1989). Here, the interaction of 
pentameric anti-HEL mAb with HEL was not inhibitable by HEL in 
ELISA; monomeric mAb derived by reduction and alkylation of the 
pentamer was readily inhibitable. In this case the pentameric 
structure and resultant multivalent binding did not allow 
displacement of the bound antigen by the soluble inhibitor. 
Additionally, the pentameric form was polyreactive in ELISA, binding 
a variety of other proteins including self antigens, while the 
monomer was specific for HEL. Hence, the biologically active levels 
of reactivity (and poly- or autoreactivity) observed with pentameric 
IgM are thought to be due to multivalent antigen binding (Hirayama 
et al. 1985; Poncet et al. 1988; Mallet et al. 1989). 
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The mAb valence for the 9.2 kd is 2, while the mAb valence for 
the 7.0, 4.7, 2.3 kd is from 6 to 10. Of interest, mAb affinity was 
inversely related to mAb valence. This result is consistent with 
studies of the interaction between haptens and IgM where it has been 
found that IgM may have low valence and high affinity binding sites 
or high valence paired with low affinity binding sites (Pascual and 
Clem, 1988; Giles et al. 1983). The low valence found associated 
with high affinity in these experiments may indicate that the larger 
antigens have more epitopes than the smaller antigens. As 
discussed, the larger number of epitopes could promote higher 
affinity binding; at the same time, the larger number of epitopes 
could occupy more paratopes and thus prevent measurements of higher 
valence. However, calculation of antigen valence for these antigens 
according to the method described by Van Regenmortel (1988) for IgG 
Fab was not possible because of the complication introduced by in-
tact multivalent IgM. 
SCM antigens retain reactivity following heat-denaturing conditions 
The binding characteristics of the different SCM polypeptide 
antigens in affinity chromatography and ELISA can be explained as 
the effect of increasing molecular size and complexity on the stab-
ility of antigenic conformations (Gras-Masse et al. 1988) • An 
alternate interpretation is that the membrane antigen has repeating 
sequential epitopes, and that the polypeptides evaluated are 
fragments derived from this repeating epitope structure. The 
repeating epitope is not likely to be carbohydrate, since amino acid 
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analysis of SCM and the SCM fractions reveals no amino sugars. 
Furthermore, the molecular weights of the SCM fractions as 
determined by amino acid analysis agree with the molecular weights 
determined by HPLC, which also suggests that these are non-
glycosylated polypeptides. The epitopes would most likely be defined 
by repeating polypeptide sequence or conformation. 
Conformation may be negligible in these small polypeptides. In 
studies of secondary structure stability it was found that helix 
formation is at most negligible for short peptides (< 13 residues) 
(Sundaralingam et al. 1985). The stability of secondary structures 
and helices was strongly dependent on the number of residues capable 
of forming intrapeptide salt bridges. Thus, a minimal size as well 
as appropriate composition are required for short peptides to assume 
stable secondary structures (Padmanhabhan et al. 1990). If conforma-
tion is achieved by the SCM antigens in solution, the larger SCM 
antigens may be able to acquire more stable secondary structures 
than the smaller antigens. Existing conformation would then be 
disrupted by the denaturing effect of heating, yielding additional 
sequential determinants. 
Heating proteins at l00°c has been shown to cause irreversible 
denaturation (Ahern and Klibanov, 1985; Kenett et al. 1990). 
However, the disruption of conformation of some proteins has been 
shown to be reversible upon contact with antibody in solution. 
Appropriate binding conformation can be induced in a protein by 
antibody in solution (Sela, 1966; Djavadi-Ohaniance et al. 1984). 
But these polypeptides are coated on polystyrene plates where it may 
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be assumed that their conformation (whether native or denatured) 
remains fixed after coating. Several investigators have shown that 
proteins are denatured by coating to plastic or nitrocellulose mem-
branes. mAbs which bind exclusively the solid phase form of tryp-
tophan synthase do not bind the enzymatically active (native) 
protein in solution (Djaravadi-Ohaniance et ~- 1984; Friguet et ~. 
1984). Furthermore, these mAbs can bind the denatured protein in 
solution, indicating that the solid phase protein is also denatured. 
Similar results were obtained for a-mannosidase (Mierendorf and 
Dimond, 1983), rat brain hexokinase (Finney et al. 1984), ~. coli 
F1-ATPase (Dunn et ~- 1984), lactate dehydrogenase and creatinine 
kinase (Vaidya et al. 1985), bovine serum albumin (Smith and Wilson, 
1986) , and lysozyme ( Kenett et al. 1990) • Therefore, because the 
small size of the SCM polypeptides precludes significant secondary 
structure and because the denaturing conditions of boiling and plate 
coating eliminate existing secondary structure, the reactivity of 
these antigens is thought to be due to their primary amino acid 
structure. 
Amino acid composition is related to antigen binding characteristics 
Denaturing conditions did not destroy reactivity of these 
antigens, and in fact, appeared to increase reactivity. Since ap-
parent N-terminal blocking prevented amino acid sequencing, amino 
acid analysis of the SCM antigens was performed to determine whether 
amino acid compositions could be related to these observations. 
The MWs as determined by HPLC agreed with those obtai~ed by 
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amino acid analysis, suggesting that these polypeptides are non-
glycosylated and that the epitopes lie in the amino acid structure. 
These antigens showed a recurrence of particular amino acids, espe-
cially the relatively acidic amino acids and aliphatic side chain 
amino acids. Critical amino acids may be those which increase in 
number directly with antigen size; these include Asp, Thr, Ser, Glu, 
Gly, Ala, Val, Ile, and Leu. The most acidic, Glu and Asp, in-
creased the most with antigen size, nearly doubling with each ap-
proximate double in antigen size. The relative acidity of these 
antigens paralleled the increase in antigen size, reactivity and mAb 
affinity for these antigens, suggesting a role for these amino acids 
in mAb recognition. Of note, these same amino acids were previously 
shown to be in abundance in immunologically-related peptides iso-
lated from GBM (Lange, 1969). 
These acidic amino acids are among the most hydrophilic and 
predictions of antigenic determinants based on hydropathicity prof-
iles often show them as contributing to charged topographic epitopes 
(Hopp, 1986). A structural motif consisting of charged groups may be 
the minimal requirement for expression of an epitope (Edmundson et 
al. 1987; Payelle-Brogard et al. 1989; Stollar et al. 1989). 
~ proposed structure for the SCM antigens 
The SCM antigens described here are related by their ability to 
bind a mAb cross-reactive with BM. Therefore these antigens have 
significant structural similarities. However, analysis of the 
interaction of these antigens with mAb shows that these antigens 
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vary in their reactivity and affinity. A structural basis for these 
differences was sought; amino acid analysis showed that the 
abundance of acidic amino acids was directly related to affinity and 
reactivity. When it was shown that these antigens were reactive 
following denaturing conditions, it was concluded that the amino 
acid sequence determined the expression of the epitopes. To 
accomodate all of these observations, a model for the structure of 
the SCM antigen is proposed in which the protein antigen's amino 
acid sequence contains a periodic distribution of acidic amino acid 
residues. 
This model implies that these low MW polypeptides are antigenic 
subunits which can be derived from a larger antigen simply by 
proteolytic- cleavage of the larger segment. Amino acid analysis 
showed that tryptic cleavage sites are available in the 20 and 13 kd 
SCM antigens; these sites may allow the generation of the smaller 
(11-2.3 kd) antigens. That some tryptic sites remain in these 
larger antigens suggests that trypsin digestion was incomplete. It 
has been shown that Arg or Lys which have at their C terminus an 
amino acid residue with anionic side chains (i.e. hydroxyl or car-
boxyl groups) are relatively resistant to trypsin cleavage (Smith et 
~· 1963; Canfield, 1963; Ambler and Brown, 1967). The abundance of 
Asp, Glu, Thr and Ser in these antigens may partially protect some 
potential trypsin sites. 
The occurrence of repeating epitopes would give the smaller 
antigen fragments certain predictable characteristics. These in-
elude size-dependent differences in number of epitopes and ~esulting 
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differences in reactivity and affinity for the same antibody. Im-
munochemical analysis shows that the SCM antigens have these charac-
teristics. Since structural analysis was limited to amino acid 
analysis, the confirmation of this model for the SCM antigen must 
rely on inferences from the amino acid composition data. That anti-
gen size, affinity, and reactivity are correlated with the abundance 
of acidic amino acids suggests that these amino acids contribute to 
the epitope. 
To describe the epitope as a "discontinuous linear array of 
acidic amino acids" is to describe a rather ill-defined epitope. Do 
such epitopes exist, and if so, do they have immunologically sig-
nificant interactions with antibody? Recent studies have indicated 
that the occurrence of a linear array of charged amino acids can be 
quite sufficient for the expression of an epitope (Edmundson et ~. 
1987; Payelle-Brogard et al. 1989; Stollar et al. 1989). Such 
epitopes are often seen along the ridges of coiled proteins like 
collagen (Izui et al . 1976) or M protein (Gras-Masse et al. 1988). 
However, the SCM antigen may be defined by primary amino acid acid 
structure. Can a primary amino acid structure have these same 
characteristics? Recent studies were performed to identify the 
antigenic determinants of peptides derived from the breakdown of on-
cogene proteins (Appel et al. 1990). The major antigens were 
polypeptides of 13-30 residues and thus serve as a good point of 
reference for the SCM antigens. By synthesizing a series of 
peptides with single residue substitutions along the length of this 
peptide, it was possible to evaluate the contribution of each amino 
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acid to its antigenicity. The antigenic determinant was linear and 
about 4-6 residues in length. The amino acids found to be most 
important for the expression of the epitope were the aromatic amino 
acids and the charged hydrophilic amino acids and alanine. 
Furthermore, replacement of an aromatic with an aromatic or a 
hydrophilic with another hydrophilic did not affect antigenicity, 
suggesting that the determinant is defined by general 
characteristics of residues. Also, alanine could be substituted 
along the length of the polypeptide with little effect on 
antigenicity, suggesting that the precise sequence of residues is of 
secondary importance; though the determinant is linear, it is dis-
continuous. Thus the determinant is defined by spaced aromatic and 
charged amino acids (Appel et al. 1990). Finally, peptides with the 
intact determinant were able to interact with mAb in solution as 
measured by an inhibition ELISA, indicating that epitopes of this 
nature are quite capable of binding Ab and are thus of immunologic 
significance. Other investigators have demonstrated the existence 
of linear protein epitopes in influenza virus hemagglutinin defined 
simply by spaced amino acids (Jackson ~ al. 1986 and 1988; Schoofs 
et al. 1988). 
These data have implications for the structure of the im-
munologically related basement membrane antigens (Markowitz and 
Lange, 1964; Fitzsimons et al. 1987) • The immunologic relatedness 
of SCM and basement membrane antigens may be manifested in repeating 
epitopes in both membranes. Though the SCM epitope appears to be 
defined by the amino acid sequence, possibly by the repeating occur-
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rence of acidic amino acids, the basement membrane epitope need not 
also be defined by amino acid sequence, despite similar amino acid 
compositions (Lange, 1969). The minimal requirement for the expres-
sion of the mammalian autoantigen may be a similarly distributed 
topography of charged groups resulting from protein conformation. 
Low molecular weight antigens may have role in APSGN 
These SCM antigens may have a role in the development of APSGN. 
The immune complex model for APSGN would suggest that low MW 
antigens induce the formation of circulating immune complexes which 
become trapped in the renal glomerulus (Michael et al. 1966), 
leading to the characteristic immunopathology seen in APSGN. The 
autoimmune/molecular mimicry model for APSGN would propose that SCM 
antigens bear epitopes common to BM and that the immune response to 
SCM antigens becomes directed at the mammalian antigens (Markowitz 
and Lange, 1964; Lange et al. 1985, 1986; Fitzsimons et al. 1987). 
These data will be discussed first in the light of the immune 
complex model for APSGN. This model proposes that circulating 
streptococcal antigens combine with IgG and IgM to form immune 
complexes which deposit in the glomerular basement membrane (Michael 
~ al. 1966). The immune complexes then activate complement, 
releasing vasoactive amines and chemotactic peptides. This results 
in increased permeability of glomerular capillaries and the recru-
itment of neutrophils and polymorphonuclear lymphocytes. 
Neutrophils attempt to phagocytose the immune complexes. When small 
complexes in subepithelial deposits cannot be phagocyto_sed, the 
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cells release their lysosomal enzymes which degrade the GBM. The 
GBM filtration capacity is destroyed and the individual develops 
acute renal failure. The recovery from acute nephritis occurs due to 
the eventual clearance of the circulating immune complexes. 
Phagocytic clearance may become more efficient due to the formation 
of larger immune complexes or because the antibody response matures 
to produce higher affinity antibody (Haakenstad and Mannik, 1977). 
Do the observations from this thesis support this immune com-
plex scenario? First, the low MW SCM polypeptides described here 
may contribute to the formation of circulating immune complexes that 
persist in circulation since immune complexes consisting of Ig and 
low MW antigens tend to remain small and thus persist in circulation 
longer (Haakenstad and Mannik, 1977). Second, the low affinity IgM 
mAb in this study may favor the formation of persistent immune com-
plexes (Haakenstad and Mannik, 1977). Third, low MW immune com-
plexes form subepithelial deposits while large immune complexes form 
endothelial deposits in the glomerulus (Haakenstad and Mannik, 
1977). Subepithelial deposition of immune complexes is charac-
teristic of APSGN, and has been observed in murine GBM following in-
jection of this mAb (Lange, 1980a; Lange et al. 1985). 
Though low MW antigens and low affinity antibody may have a 
role in the formation of immune complex-induced nephritis, a criti-
cal characteristic of this laboratory's animal model for APSGN is 
inconsistent with the immune complex model. This animal model sup-
ports the autoimmune/molecular mimicry model because the model shows 
that injection of this mAb alone is sufficient for inducing 
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nephritic syndrome in mice (Lange, 1980a; Lange et~. 1985, 1986). 
At no time do these animals receive streptococcal antigen. 
Furthermore, the mAb can be demonstrated in these animals' kidneys 
by immunofluorescence and can be eluted from kidney tissue (Lange 
1980a; Lange et al. 1985). These o~servations suggest that the 
initiation of disease is due to cross-reactive antibody binding to 
specific kidney antigens. 
This thesis also provides data concerning the chemical nature 
of SCM antigens which do not support the immune complex model. Im-
mune complexes, antibodies, antigens, and other molecules which are 
cationic are preferentially trapped in the glomerulus because the 
GBM has a net negative charge (Rennke et al. 1975; Mannik et al. 
1987). The SCM antigens were abundant in acidic amino acids. The 
pis of serine, threonine, aspartic acid, and glutamic acid are 5.68, 
6.53, 2.97, 3.22, respectively. Thus at physiological pH these 
amino acids would be negatively charged and would not be susceptible 
to entrapment in GBM. 
How do these antigens trigger the autoimmune response? The 
immune response to streptococcal antigens during infection may be 
immediately cross-reactive with kidney antigen or it may become a 
cross-reactive response when other factors allow the expression of 
kidney autoantigens. In the first case, antibodies to streptococcal 
antigens bind immunologically-related GBM antigens which are readily 
available and presumably are expressed prior to infection. In the 
second case, streptococcal infection causes the expression of novel, 
modified, or previously sequestered antigens. In either case, it is 
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the similarity of bacterial and mammalian protein antigens that ac-
counts for the cross-reactive immune response. 
Bacterial protein antigens that are immunologically related to 
manunalian antigens have been linked to the development of other 
autoimmune diseases. Adjuvant arthritis has been induced in rats by 
a 65 kd antigen of Mycobacterium tuberculosis (van Eden filO. s..J..., 
1988). Adjuvant arthritis T-cell clones were used to screen 
genetically engineered truncated proteins and synthetic peptides 
derived from this 65 kd protein, and a nonapeptide from this antigen 
has been identified that is similar to a nonapeptide from the link 
protein of rat proteoglycan (van Eden et al., 1988). The shared 
amino acids may constitute a shared epitope, and therefore may be 
responsible for the development of autoreactive T-cells in adjuvant 
arthritis. 
Ankylosing spondylitis (AS) and Reiter's syndrome (RS) are 
often cited as classic examples of molecular mimicry-associated 
autoimmune disease (Schwimmbeck filO. al. 1987). These non-rheumatoid 
arthritic diseases of unknown etiology have been associated with in-
fections by Salmonella, Shigella, Yersinia, and especially 
Klebsiella pneumoniae. Schwimmbeck et al. (1987) reported that sera 
from HLA 827+ AS and RS patients contained antibodies which 
recognized an epitope in K· pneumoniae nitrogenase and in HLA 827. 
The shared epitope was defined by six consecutive amino acids. Such 
a similarity would explain the high incidence of the HLA 827 
haplotype within the AS and RS patient population. Other infectious 
agents have proteins that share stretches of consecutive amino acids 
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with specific mammalian proteins. Moreover, these common antigenic 
determinants are associated with the development of autoimmune dis-
ease: examples include streptococcal M protein and cardiac myosin in 
rheumatic heart disease (Krisher and Cunningham, 1985); adenovirus 
and A-gliadin in ulcerative colitis (Kagnoff et al. 1984); several 
viruses and myelin basic protein in experimental allergic 
encephalomyelitis 
Oldstone, 1986). 
( Dyrberg and Oldstone, 1986; Fu j inami and 
As in many infection-associated autoimmune diseases, the in-
fectious organism can not be isolated from patients with APSGN 
(Rodriguez-Iturbe, 1984). This suggests that the autoimmune disease 
is initiated during infection and then perpetuated by the presence 
of autoantigens. It is proposed that the SCM antigens described in 
this thesis may have a specific role in the initiation and 
perpetuation of autoreactivity. Following infection, these antigens 
could bind low affinity antibody which is cross-reactive with GBM 
epitopes. This low affinity antibody could then bind exposed GBM 
epitopes; whether disease would be initiated at this point is not 
known. However, the antibody titer and affinity may mature because 
of the persistence of SCM antigens: the low affinity antibody 
binding and low molecular weight of the SCM antigens would favor the 
formation of small circulating immune complexes which tend to 
persist. Furthermore, persistence in circulation would be enhanced 
by the charge properties of these antigens. Maturation of antibody 
affinity and increase in titer could then lead to the critical 
density of antibody on GBM required to activate complement, 
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resulting in tissue damage. Such damage may then expose more GBM 
epitopes, leading to disease in the absence of streptococcal 
infection or antigens. 
SUMMARY 
The etiology of acute post-streptococcal glomerulonephritis, an 
autoimmune disease, may be explained in part by immunologic 
similarities between streptococcal membrane antigens and glomerular 
basement membrane. Because of this immunologic similarity, the 
protective immune response to streptococcal infection becomes 
destructive to host tissue. Support for this hypothesis is the 
observation that antisera and monoclonal antibodies to streptococcal 
membrane bind directly to glomerular basement membrane and cause 
disease in mice in a dose-dependent fashion. 
This dissertation describes immunochemical properties of 
streptococcal cell membrane (SCM) protein antigens which were iso-
lated using anti-SCM monoclonal antibody (mAb) cross-reactive with 
glomerular basement membrane (GBM). 
Previously observed immunologic relatedness between SCM and 
basement membrane (BM) was confirmed by the isolation of a distinct 
antigen from each membrane by affinity chromatography with anti-SCM 
mAb. One major antigen was isolated from SCM, GBM, and lung 
basement membrane (LBM); these were 20 kd from SDS-solubilized SCM 
and 13, 11, 10 kd from trypsin-digested SCM, GBM, LBM, respectively. 
The antigen-mAb combining ratios on the affinity columns differed 
for each antigen and were found to be 2: 1, 1: 1, and 3: 1 for SCM, 
GBM, LBM, respectively. These differences were thought to be due to 
differences in the antigens' relative number of epitopes. 
Several low MW (11.6, 9.2, 7.0, 4.7, 2.3 kd) SCM antigens also 
present in the SCM trypsin digest but not selectively bound by the 
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affinity column were prepared by HPLC and subsequently found to be 
reactive with the mAb. These antigens bound the affinity column 
when applied individually, though they bound at different ef-
ficiencies. The % binding increased with the size of the individual 
antigen. Furthermore, these antigens were equally reactive with mAb 
when present in equal ug amounts in solid phase ELISA. Moreover, 
these SCM antigens inhibited mAb in a dose-dependent fashion with 
the degree of inhibition directly related to antigen size. 
Collectively, these results show that the reactivity of these 
antigens is related to their size. 
The affinity of the mAb for the 9.2, 7.0, 4.7, 2.3 kd antigens 
was measured by equilibrium dialysis. The Keis were directly related 
to antigen size and ranged from 10-7 to 10-S. Valence of the mAb 
also varied for each antigen and was found to be inversely related 
to antigen size. The mAb valence was 2.0 for the 9.2 kd antigen and 
approximately 6. 0 for the 7. 0 kd. Saturation of mAb with the 4.7 
and 2. 3 kd antigens was difficult to achieve and thus the mAb 
valence for these antigens could only be estimated (6-10). These 
results show an increase in affinity of the mAb and a decrease in 
mAb valence with increasing antigen size. These observations are 
consistent with the observations that these antigens differ in their 
reactivities with antigen size. Increasing affinity with size of 
the antigen may be explained by the presence of multiple epitopes 
which permit multivalent and higher affinity interactions with mAb. 
The structural basis for these observations was investigated. 
First, the SCM antigens were subjected to denaturing conditions and 
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were found to retain reactivity with the mAb. This suggests that 
the epitope is defined by the primary amino acid structure. Second, 
amino acid analysis of these antigens showed that the MW of each 
antigen agreed with that obtained by HPLC gel filtration, suggesting 
that the antigens are not glycosylated. Finally, the abundance of 
acidic amino acids (especially Glu, Asp, Thr, Ser) and aliphatic 
side chain amino acids (notably Ala, Val, Ile, Leu) was directly 
related to the previously observed reactivities and affinities. 
Taken together, these observations suggest that the epitope is 
defined by the linear amino acid structure of these polypeptides, 
possibly by the presence of acidic amino acids. Furthermore, to ac-
count for the changes in reactivity and affinity with antigen size, 
it is proposed that these antigens may contain epitopes composed of 
repeating units of these amino acids. 
The amino acid composition of these antigens is distinctly 
different from other nephritis-associated streptococcal proteins and 
thus may be a novel antigen related to post-streptococcal 
glomerulonephritis. 
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